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Abstract
A good QSAR model comprises several components. Predictive accuracy
is paramount, but it is not the only important aspect. In addition, one
should apply robust and appropriate statistical tests to the models to assess
their signiﬁcance or the signiﬁcance of any apparent improvements. The
real impact of a QSAR, however, perhaps lies in its chemical insight and
interpretation, an aspect which is often overlooked.
This thesis covers three main topics: a comparison of contemporary
classiﬁers, interpretability of random forests and usage of interpretable de-
scriptors. The selection of data mining technique and descriptors entirely
determine the available interpretation. Using interpretable approaches we
have demonstrated their success on a variety of data sets.
By using robust multiple comparison statistics with eight data sets we
demonstrate that a random forest has comparable predictive accuracies to
the de facto standard, support vector machine. A random forest is inher-
ently more interpretable than support vector machine, due to the underlying
tree construction. We can extract some chemical insight from the random
forest. However, with additional tools further insight would be available.
A decision tree is easier to interpret than a random forest. Therefore, to
obtain useful interpretation from a random forest we have employed a se-
lection of tools. This includes alternative representations of the trees using
SMILES and SMARTS. Using existing methods we can compare and clus-
ter the trees in this representation. Descriptor analysis and importance can
i
be measured at the tree and forest level. Pathways in the trees can be
compared and frequently occurring subgraphs identiﬁed. These tools have
been built around the Weka machine learning workbench and are designed
to allow further additions of new functionality.
The interpretability of a model is dependent on the model and the de-
scriptors. They must describe something meaningful. To this end we have
used the TMACC descriptors in the Solubility Challenge and literature data
sets. We report how our retrospective analysis conﬁrms existing knowledge
and how we identify novel C-domain inhibition of ACE.
In order to test our hypotheses we extended and developed existing soft-
ware forming two applications. The Nottingham Cheminformatics Work-
bench (NCW) will generate TMACC descriptors and allows the user to
build and analyse models, including visualising the chemical interpretation.
Forest Based Interpretation (FBI) provides various tools for interpretating
a random forest model. Both applications are written in Java with full
documentation and simple installations wizards are available for Windows,
Linux and Mac.
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Chapter 1
Introduction
1.1 Industrial overview
There has been an increasing push within the pharmaceutical industry to
accelerate the output of new drugs, as many of the blockbusters approach
the end of their patents. The so called patent cliﬀ is going to impact all
big pharma at the cost of billions of USD per annum. In addition, there
has been a long term drive to decrease the length of drug discovery. The
time required to bring a drug to market takes up a large proportion of the
patent lifespan. Improvements to eﬃciency and throughput can be applied
to every step of the drug discovery process. The drug discovery process is
a long chain of research and development. A new drug will take anything
from 12-15 years to reach the market. This thesis covers techniques nor-
mally used in lead generation and lead optimisation, both very early stage.
Once a candidate compound has been validated using in silico methods,
experimental data must support the hypothesis. Many ﬁlters and models
exist to check for amongst other properties, bioavailability and toxicology.
It is far better to drop a compound early rather than late. Each month
in development accrues more expense which ultimately must be recouped
by a successful drug, before itself making a proﬁt. Candidate drugs enter
animal and human trials at great cost. Each subsequent phase of testing
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adds more rapidly increasing cost. In vitro studies are carried out ﬁrst in
test tubes before moving to in vivo studies in animals. The aim of these
studies is to assess the response in living models. The dosage is also mea-
sured. Human trials occur in several phases. Phase I is a small cohort
of healthy volunteers. The candidate drug and placebo are measured to
determine the eﬀectiveness and safety in humans. Further dosage studies
are conducted based on the animal models as they are only a guide. There
can be substantially diﬀerent responses between both. Phase II continues
to measures safety and eﬃcacy. Patients are included for the ﬁrst time in
Phase II, along with further volunteers, comprising a larger test population.
Phase III trial employ a larger group to assess a wider variety of patients.
The phase III trials typically continue while regulatory approved is applied
for. A candidate drug can be withdrawn at any stage if the trials highlight
undesirable toxicity, side eﬀects or if the drug simply does not work. Each
country requires a separate license making global distribution complicated,
lengthy and expensive. In addition diﬀerent clinical studies may be required
to comply with local law. Clinical studies continue after launch to ensure
no unforeseen issues arise as a wider population administer the drug. In
some cases side eﬀects may take years to manifest and hence clinical trials
simply cannot check for these. A recent high proﬁle case of side eﬀects was
Merck’s anti-inﬂammatory drug Vioxx. It led to an increased likelihood of
heart attack and strokes. Merck voluntarily withdrew Vioxx after subse-
quent studies conﬁrmed the link. During the clinical trials process R&D
will ﬁnd a suitable synthesis for mass production and formulation for the
chosen delivery method. Only a handful of candidate drugs ever reach the
market. Previously pharmaceuticals thrived on multiple billon dollar drugs.
Most of these reach patent expiry by 2015, leaving a huge gap in revenues.
Few new drugs have reached the same proﬁtability. In recent years it is
now harder to register a drug and more expensive. The funding bodies
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and insurance companies demand lower prices for patented drugs and when
cheaper generics are an option they are often taken. Pharma has reacted to
the changing marketplace by reshaping R&D and expanding into new ther-
apeutic areas, e.g. personalised medicines. Companies will have more drugs
targeted at smaller patient populations, while less proﬁtable, it removes the
dependence on a few top earners. Biotechnology companies were hailed as
the answer, many of which have now been bought by the pharma giants.
Pharma themselves have continued to merge as well forming even bigger
multinationals, which are now ready for restructuring and streamlining of
costs. All eﬀorts are to produce more successful drugs for a fraction of the
cost.
Patents are harder to obtain and are more frequently being challenged.
The cost to bring a successful drug to market now is 800 million to 1.3 billion
dollars. Late stage attrition is a strong contributor to this high cost. Once a
candidate enters clinical trials the investment costs jump immediately. Even
once oﬀ patent there used to be little competition from the generics. Now
it is substantial. In addition, the various agencies across the globe drive
for the cheapest price. The cost and duration of development is becoming
increasingly prohibitive. All aspects of development can and should be
reviewed to improve them. The whole ﬁeld of cheminformatics is essentially
aimed at aiding the early stages of drug discovery. Unlike other disciplines
in chemistry, cheminformatics is very closed aligned to the pharmaceutical
and agrochemical industries.
1.2 Cheminformatics
While not the most well-known part of chemistry, it plays an important
part in the delivery of in silico techniques. Cheminformatics was originally
deﬁned by Brown in 1998.1 However, the subject has been in existence far
longer. Markush structures were ﬁrst used in patents from 1924 for describ-
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ing multiple substituents. Wiswesser line notation, the ﬁrst line notation to
describe complex molecules was created in 1949.2 The American Chemical
Society created the Journal of Chemical Documentation in 1961 which has
now morphed into the Journal of Chemical Information and Modeling. It
is no longer the only journal dedicated to cheminformatics.
Pivotal to cheminformatics’ development has been the growth and ca-
pabilities of the computer, core to any cheminformatics technique. Chemin-
formatics consists of several topics, which will be discussed brieﬂy: chemical
data storage, substructure searching, similarity searching, clustering, dock-
ing and QSAR to name a few. Most techniques are available as both 2D
and 3D methods. 2D methods are primarily concerned with the topology
of molecules. Conformers and stereochemistry are typically ignored un-
like with 3D methods. 3D methods are typically more complex in order
to model the extra data. Studies have found 2D methods can sometimes
outperform 3D counterparts.3 This may sound counterintuitive but simpler
methodologies can yield better results with less computational eﬀort.
1.2.1 Chemical data storage
The electronic storage of chemical data is crucial to computational tech-
niques, yet even today there are many formats with advantages and disad-
vantages for all. While it is simple to store a chemical structure as an image
ﬁle, this encodes limited chemical information in a challenging format. Ma-
chine readable ﬁles are necessary for tools to have access to the chemical
information. A common storage method for chemical structures is using a
molecular graph. A molecular graph uses graph theory from mathematics.4
A graph is a representation of nodes and edges. In a molecule the nodes
represent atoms and edges the bonds. The atoms and bonds in a molecule
are not homogeneous. There will be several types of both, which must be
captured. A limitation of graph theory is it only details the topology of a
4
structure, e.g. what nodes are connected to which edges. There is no spatial
arrangement information. A sample graph is depicted in Figure 1.1.
Figure 1.1: A sample graph depicting 12 nodes and 11 edges, representing
propan-1-ol. The bond order is present on the edges.
Molecular graphs are the blueprints for the construction of SMILES
(Simpliﬁed Molecular Input Line Entry Speciﬁcation).5 SMILES is a com-
mon and popular format, partly due to its concise and human readable
nature. Each molecule is represented by a single line of text corresponding
to the atoms and bonds in the molecular graph. Atoms are represented
by their atomic symbol. Due to the high frequency of hydrogen and sin-
gle bonds they are implicit. Double and triple bonds are encoded as an
equals, =, and hash ,#, symbol, respectively. Aromaticity is encoded by
using lower case, c, for aromatic carbon and upper case, C, for aliphatic.
Rings are denoted by numbering the opening and closing atoms of the ring
with the same number. Multiple rings use sequentially increasing numbers
to identify them. Branching chains are handled by encasing all branched
atoms in parentheses. Table 1.1 depicts several sample SMILES.
A given molecule can have multiple, yet valid, SMILES strings. Start-
ing at diﬀerent atoms will result in a diﬀerent path through the molecule.
However, the molecule is identical. This can lead to duplicate SMILES in
5
SMILES Name Depiction
c1ccccc1 Benzene
CS(=O)(=O)c1ccc(cc1)C2-
=C(C(=O)OC2)c3ccccc3
Vioxx
CC(C)c1c(C(=O)-
Nc2ccccc2)c(c(c3ccc(F)-
cc3)n1CC[C@@H]-
4C[C@@H](O)CC(=O)-
O4)c5ccccc5
Lipitor
CN1CC[C@]-
23[C@H]4Oc5c3c-
(C[C@@H]1[C@@H]-
2C=C[C@@H]4O)ccc5O
Morphine
Table 1.1: Examples of SMILES
6
a database, which is highly undesirable. To provide a unique representa-
tion the SMILES must be canonicalised. All variations of a single molecule
should resolve to the same canonical SMILES.6 There are now various algo-
rithms for canonicalisation. Used consistently they provide unique SMILES.
Although the molecular graph does not contain any spatial data, SMILES
can encode limited stereochemical information, such as chiral centres and
cis-trans isomers. As SMILES do not contain spatial information they are
not suitable storage for 3D methods. In docking the ligand and protein, 3D
information is paramount to the technique. 3D information is stored us-
ing connection tables which contain Cartesian coordinates. Many formats
use this method such as PDB (Protein Data Bank) and SDF (Structure-Data
File). Typically the xyz coordinates of each atom are detailed along with
each bond connections by atom ID.
Competing formats have arisen over time. One such example is the
InChI (IUPAC International Chemical Identiﬁer).7 Designed by IUPAC
with an aim to be freely available, computable by anyone and have a human
readable quality, they encode more information than SMILES and address
some of its weaknesses, e.g. the need for canonicalisation for uniqueness.
The algorithm is a three step process: normalisation, canonicalisation and
serialisation. Redundant information is removed, atoms are uniquely iden-
tiﬁed and the output written as a string. Additionally, an InChIKey (or
hash) can be generated, which is not human readable and is a ﬁxed 25
character string. It was introduced for practical reasons around web based
searches as the full InChI can be overly verbose. The main InChI is com-
posed of up to six layers of information comprising the core layer, charge,
stereochemistry, isotopic, ﬁxed hydrogens and reconnected layer. The core
layer comprises three sublayers: chemical formula, connectivity and hydro-
gens. Only the chemical formula sublayer is required for a valid InChI.
Each layer, and sublayer, is delimited by a slash, /. The InChiKey is based
7
on a hash algorithm. The ﬁrst 14 characters determine the connectivity,
while all additional information is encoded in the eight characters after a
hyphen. The ﬁnal two characters encode the InChI version and a checksum.
The InChI and InChIKey for Lipitor is shown in Figure 1.2. While many
vendors have added InChI support to their applications they have yet to
receive widespread use over SMILES. SMILES have been the dominant 2D
data format for many years. An OpenSMILES speciﬁcation is being drawn
up to address the original shortcomings.8
InChI=1S/C33H35FN2O5/c1-21(2)31-30(33(41)35-25-11-7-
4-8-12-25)29(22-9-5-3-6-10-22)32(23-13-15-24(34)16-14-23)-
36(31)18-17-26(37)19-27(38)20-28(39)40/h3-16,21,26-27,37-
38H,17-20H2,1-2H3,(H,35,41)(H,39,40)/t26-,27-/m1/s1
OUCSEDFVYPBLLF-KAYWLYCHSA-N
Figure 1.2: InChI and InChIKey for Lipitor.
Complementing SMILES are SMARTS, SMiles ARbitrary Target Speci-
ﬁcation,9 a query language to search compound collections. Similar notation
to SMILES is used, such as bond notation. Additional syntax is required to
capture regular expression patterns. Carbon can be matched with its atomic
number, [#6], aliphatic or aromatic carbon, [C,c] or the atom wildcard, *.
Connectivity can be speciﬁed using [CX4], where the carbon must have four
bonds. Carboxylic acid is represented as [CX3](=O)[OX2H1], a carbon with
three bonds, connected via a branched double bond to an oxygen and to an-
other oxygen. The second oxygen has two bonds, one of which connects to a
single hydrogen. Logical operators of and, ;, and or,,, are available to form
patterns such as a primary amide: [N;H3;+][C;X4], charge represented
by + or -. SMARTS therefore represent a powerful yet ﬂexible query lan-
guage in which to encode chemical queries. SMARTS are routinely used in
substructure searching, fragment based approaches, scaﬀold building and
combinational chemistry. SMARTS are more complicated than SMILES,
but encode more information, and hence are typically more verbose. Table
1.2 depicts various SMARTS examples.
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SMARTS Name Depiction
[CX4] Alkyl carbon
[CX3]=[OX1] Carbonyl group
[$([CX3]=[OX1]),-
$([CX3+]-[OX1-])]
Carbonyl group,
either resonance
form
[#6][F,Cl,Br,I] Carbon attached
to a halide
Table 1.2: Examples of SMARTS
9
The plethora of chemical formats now available can pose a barrier, es-
pecially as commercial vendors typically introduce their own as well (e.g.
oeb from OpenEye and moe from the Computing Computing Group). Var-
ious conversion tools exist. The best known is open Babel. However, some
formats are less formalised than others leading to incorrect conversions.
1.2.2 Substructure searching
Often a database of compounds needs to be searched. Using either SMILES
or SMARTS, depending how precise the query is, this can be quickly achieved.
Many search methods already exist within graph theory. Substructure
searching is essentially comparing two graphs to see if the query graph is rep-
resented in the other. This is known as subgraph isomorphism. Established
subgraph searching methods perform poorly in large chemical databases, as
they are exhaustive searches. A two step process is now used, in which the
ﬁrst step removes the majority of query compounds, leaving a minority for
the exhaustive subgraph matching. A binary representation of the molecule
is used, as binary calculations can be performed very eﬃciently. A chemical
dictionary is used to represent the structural features present in a molecule.
If a given feature is present a 1 is entered to the bitstring, otherwise a 0.
In order for the molecule to pass onto subgraph matching the bitstrings
must match. Therefore, as soon as diﬀerences appear in the bitstring the
compound is discarded, as it will not match. Using the reduced database
the subgraph isomorphism search is executed. It belongs to a class of prob-
lems known as NP -complete. NP -complete problems are characterised by
an exponential relationship between the amount of time required and the
size of the problem. This is because they are an exhaustive or brute-force
approach. Therefore, it is prudent to avoid them when possible.
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1.2.3 Similarity searching
Substructure searching is useful but often we do not have a complete query
or want to ﬁnd an alternative structure. Similarity searching is based on
the similar property principle that states similar structure often leads to
similar properties.10 Therefore, the ability to ﬁnd similar compounds is of
interest. SMARTS could be constructed to become increasingly fuzzy, but
to capture all possibilities is non-trivial. Sometimes only a small fragment
of interest is known and one needs to ﬁnd similar compounds. When dealing
with 3D structure, similar compounds are more relevant than substructure
matches, as the conformation becomes increasingly important. 2D similarity
is computed by using the bitstrings used for substructure searching.
Molecular ﬁngerprints are the bitstring representation of molecules us-
ing binary values.11 Two ﬂavours exist, the use of a fragment dictionary
and hashed ﬁngerprints. Fragment dictionaries use a predetermined list of
structural features to represent each bit. Thus, you can map back to the
structural element from the bitstring. This can make interpretation more
accessible. Using hashed methods a predeﬁned dictionary is not required, an
advantage as any fragment present will be encoded. Using a dictionary you
control what fragments are available and therefore can bias the ﬁngerprint.
Hashed ﬁngerprints are unique per dataset and not readily interpretable in
the same manner as a dictionary method. Fingerprints are now a popu-
lar basis for descriptors, even though their conception was never intended
for this. 2D ﬁngerprints were originally developed to accelerate substruc-
ture searching algorithm performance.11 There is no intrinsic reason why
they should perform well as descriptors. The good performance is likely
because the molecule’s properties and biological activity are dependent on
the features encoded by the ﬁngerprint.
A similarity coeﬃcient is required to compare the bitstring representa-
tion of molecules. There are numerous similarity coeﬃcients available. One
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of the most common is the Tanimoto (or Jaccard) coeﬃcient. It can be
expressed as SAB,
SAB =
c
a+ b− c (1.1)
where a are the bits sets in that target structure, b the bits set in the
database structure and c the bits set common in both structures. The result
is a value between zero and one, where zero is no similarity and one an exact
match. Results can then be sorted or restricted based on this measure. In
addition to the other coeﬃcients used in other disciplines similarity can also
be calculated via compression.12
1.2.4 Clustering
Cluster analysis is useful for large data sets. Clustering aims to group sim-
ilar compounds together. The similarity of the group members could be
activity, therapeutic target or mode of action depending on the descriptors
available. Typically clusters are made based on distance measures between
other members of the data set. Most methods are also non-overlapping;
each member belongs to only one cluster. Two types of methods are com-
mon: hierarchical and non-hierarchical. Hierarchical methods compare all
members to each other. They create clusters of decreasing size, with each
smaller cluster being a subset of the larger cluster. They are much like a
decision tree in this respect, especially as a dendrogram is used for visual-
isation. Unlike a decision tree the clusters start as single compounds and
grow as members are reorganised from the bottom up. Ward’s method is
based on distance from one member to all others with the aim of minimising
variance, without a dendrogram.13 The user often needs to pick the number
of required clusters. This can be done manually retrospectively or cluster
level selection methods now exist to determine a balance of cluster num-
ber and tightness of the clusters. The Jaccard statistic is used to compare
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cluster groupings. Non-hierarchical clustering is normally done using the
Jarvis-Patrick method.14 The data set is only read once in this method.
The ﬁrst compound forms the ﬁrst cluster. The second joins if a criterion is
met otherwise it forms a new cluster. Hierarchical clustering allows multiple
comparisons of all data points. A drawback of this method is the presence
of singletons, clusters with one member. By altering the rules for joining or
making a new cluster the number of singletons can be reduced.
1.2.5 Docking
Docking is typically used to model how a given set of ligands would interact
with a protein. Many drugs have protein targets and understanding their
interaction is key to designing a potent compound. This is a 3D experiment
where the conformation of the ligand in the protein pocket, or binding site,
is explored to ﬁnd the most energetically favourable pose. Protein structures
are not ﬁxed. The presence of a ligand will by design alter the conformation
of the protein. This may be key in allowing the ligand to bind. Accurate
protein behaviour is important to modelling realistic binding. The solvent
of the system should also be taken into account as gas-phase simulations are
not representative of a biological system. Ideally an experiment will start
with a known crystal structure to which a theoretical ligand will be bound.
A sample docking of the actual structure and best pose is shown in Figure
1.3. Initial methods assumed rigid-body structures, which is not ideal. More
modern techniques allow ﬂexible docking of both protein and ligand giving a
more accurate representation. Flexible docking is far more computationally
expensive, especially when a large set of ligands is used. Docking is a
challenging technique as there are many hurdles. The crystal structure of
the protein is the interpretation of the original crystallographer. Protein
structures devised from homology modelling are even more subjective. If
the protein structure is incorrect expecting reasonable binding energies is
13
unrealistic. The binding energy represents the non-covalent interactions
between the ligand and protein. A force ﬁeld approach would use van der
Waals and electrostatic interactions between all atoms of both molecules to
predict the binding energy.
Figure 1.3: Docking example. Only the atoms in the box are used for
calculation purposes. The red molecule is the crystal structure and blue the
best docked pose.
1.3 Quantitative Structure-Activity Relation-
ships
QSAR (Quantitative Structure-Activity Relationship) is the focus of this
thesis. It was ﬁrst used in the seminal work by Hansch15,16. Hansch devised
an equation relating descriptors of electronic properties and hydrophobicity
to biological activity.
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log
(
1
C
)
= k1 logP + k2σ + k3 (1.2)
where C is the concentration of compound needed to produce a standard
response in a given time. logP is the octanol-water partition coeﬃcient
and σ is the Hammett substitution parameter. Hansch also proposed that
activity was parabolically dependent on logP :
log
(
1
C
)
= −k1 (logP )2 + k2 (logP ) + k3σ + k4 (1.3)
The reasoning for parabolic dependence on logP was the compound
hydrophobicity should not be so low as not to cross the cell membrane, or
so high that once in the membrane it remains in situ. Electronic parameters
are important in determining activity. The Hammett parameters come from
Equations 1.4 and 1.5. The equations quantify related compound reaction
rates and positions of equilibrium.
log
(
k
k0
)
= ρσ (1.4)
log
(
K
K0
)
= ρσ (1.5)
where k is the rate and K is the equilibrium constant for a particular sub-
stituent relative to a reference compound (typically hydrogen, corresponds
to k0 and K0). Hammett used the hydrolysis of benzoate esters to measure
reaction rates and ionisation constants of substituted benzoic acids for equi-
libriums. The parameter σ is determined by the nature of the substituent
and whether is is meta or para to a group on the aromatic ring. The reac-
tion constant ρ is ﬁxed for a particular process. Since Hammett’s original
work17 there have been various advances.18
Modern QSAR is more ambitious in the number and variety of descrip-
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tors considered. There are three components to a QSAR model: the data,
how one represents the data and the statistical technique chosen to ﬁnd a
relationship between them. All three aﬀect the overall model produced. All
models should be thoroughly validated to ensure they are predictive. While
the classic QSAR dataset is small (about 30 compounds) it is now widely
acknowledged that this can be too small.19 One cannot expect to ﬁnd a
relationship from so few datapoints. 60 compounds has been suggested as
the minimum size for a dataset.20
Tens of thousands of descriptors can be readily generated in silico. On
ﬁrst inspection one may think more descriptors means an improved model.
However, in reality the noise and cross-correlation of the descriptors can
confuse the learning algorithm. Better performance can be achieved with a
smaller number of descriptors. Indeed techniques exist to perform attribute
selection before building the primary model as increased descriptors can im-
pact the model generation signiﬁcantly. Some machine learning techniques
inherently perform this step.
Popular algorithms for QSAR are decision trees, neural networks, genetic
algorithms, support vector machine (SVM), partial least squares (PLS) and
ensemble methods, e.g. random forests. Further details of these algorithms
is detailed in Chapter 2. The literature is full of examples of all these
algorithms on various targets and various comparisons. Although no modi-
ﬁcation to the algorithm is required, many algorithms have had some mod-
iﬁcation, for example making neural networks more interpretable21,22, con-
structing chemical kernels23,24 for SVM and multiple variations on PLS25,26.
Recently, several articles have questioned the usefulness of QSAR, for
example, when excellent models in terms of q2 (deﬁned in Chapter 2) can
be found between number of brooding storks and newborn babies (Figure.
1.4).27 How can we expect QSAR to ﬁnd meaningful chemical relationships
when, it seems, anything can correlate? The key is not changing the tools,
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but ensuring they are used correctly. Larger data sets and interpretable de-
scriptors, are just two areas for improvement. The use of multiple statistics
to measure the model, not just q2 is important, as a single statistic can be
misleading. Rigorous statistics should be used to compare techniques. The
community must push best practices to enable further advances in the ﬁeld.
Figure 1.4: A plot of the numbers of pairs of brooding storks and new-
born babies in West Germany from 1960 to 1985. Representation of
the data as a correlation plot (Inset). With permission from Springer
Science+Business Media: Journal of Computer-Aided Molecular Design,
QSAR: dead or alive?, 22, 2008, 82, Arthur M. Doweyko, Figure 1,
c©Springer Science+Business Media.
QSAR is analogous to QSPR (Quantitative structure-property predic-
tion). We show a QSPR example later when we predict solubility as part of
the solubility challenge organised by the Journal of Chemical Information
and Modeling. Solubility is an important property of a drug, but hard to
estimate both experimentally and computationally. It is the ability of a sub-
stance to dissolve in a solvent. Drugs need to be water soluble in order to be
orally bioavailable, which is the preferred method of administration. Drugs
which are not water soluble cannot be tested in biological assays, have poor
pharmacological proﬁles and tend to precipitate in storage.28 Solubility is
one of the contributing factors to the high attrition rates in drug discovery,
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which must be reduced. Current computational models for solubility can
have an error of an order of magnitude. This is compounded by a lack of
reliable and reproducible experiment data.
Drug discovery is a multi-variate problem. For example, while one can
create a model for activity, it is useless if the compounds do not have a
suitable solubility. Even once these are overcome, other obstacles will likely
challenge the path to successful registration. Many factors contribute to sol-
ubility, making prediction challenging. These include lipophilicity, number
of hydrogen bonds formed in solvent, the ability to form intramolecular hy-
drogen bonds, the ionisation states of functional groups and the properties
in crystal form.29
The ﬁeld, in general, has seen numerous advances over the last few
decades especially in QSAR, mainly from 2D all the way to 6D. Admittedly
2D and 3D are the most commonly used. 2D QSAR uses descriptors based
on the 2D topology of the molecule. This can include 3D values such as vol-
ume or surface area. However, these values are typically calculated without
multiple conformers and possibly without 3D coordinates if SMILES are the
input data format. 2D QSAR uses machine learning algorithms to ﬁnd a re-
lationship between the descriptors and activity. 3D QSAR has two popular
ﬂavours, Comparative Molecular Similarity Indices Analysis30 (CoMSIA)
and Comparative Molecular Field Analysis (CoMFA).31 CoMFA attempts
to ﬁnd a correlation between activity and 3D shape, electrostatics and hy-
drogen bonding. The biologically active conformation for each molecule is
required. Each conformation has molecular ﬁelds generated. The ﬁelds are
calculated with the molecule in a lattice, thus allowing comparison to all
other molecules. Typically electrostatic and steric probes are used at each
deﬁned point within the lattice. PLS is used to analyse the data generated
from the lattice. The coeﬃcients obtained from PLS allow 3D contour plots
to be generated on the lattice. The contours indicate regions where charged
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groups or steric bulk can aﬀect activity (both in a positive and negative
fashion). CoMSIA was developed after CoMFA and addresses some of its
drawbacks.
The fourth “dimension” in the paradigm is sampling and includes the
sampling of conformation, alignment, pharmacophore sites and entropy.32
The composite information coming from each of these sampled property
sets is embedded in the resulting QSAR model. Most of the other nD-
QSAR methods consider each of these properties, which are sampled as
individual dimensions in their QSAR studies. Hence one would get a 5D
QSAR33 method if conformational sampling is included, and a 6D QSAR34
approach if both conformational and alignment samplings are considered.
1.4 Pragmatic programming
Computational tools have advanced both commercially and from open source
projects. A range of programs are now available to assist from various com-
mercial suppliers. One of the most useful features is access to an application
programming interface (API), as invariably one always wants to do some-
thing slightly outside the scope of a program. Weka20 is a machine learning
workbench; Marvin35 allows for the sketching and visualisation of molecules.
Both programs are written in Java enabling them to work cross-platform.
NCW and FBI, the two packages which result from this thesis were possible
through the availability of the API for Weka and Marvin. Without the API
a huge amount of additional coding would of been required. In addition,
these tools have already been validated by the community. NCW and FBI
are discussed in Chapters 5 and 4 in more detail.
Weka is an open source application that allows us to modify the source
if necessary or extend the API. Marvin is not open source but the API
is mature and was capable of accomplishing our tasks. The modern day
computational chemist or cheminformatician requires a strong grounding in
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computer science to beneﬁt from all the tools available. Indeed, chemin-
formatics has seen a explosion of software packages and web services. This
is only set to rise as Research Councils encourage open source publication
of work they have funded. Some programs have gone on to form commer-
cial spin outs from universities. Some programs funded over the long term
have become very successful, Weka is an example, ﬁrst introduced in 1993.
From the cheminformatics world KNIME36 is becoming increasingly popu-
lar as an open source alternative to Pipeline Pilot.37 It optionally runs Weka
and use commercial plug-ins from Schro¨dinger38 who part fund its ongoing
development.
Producing programs as a result of a research projects can be problem-
atic, as once complete they often are left unmaintained. Many such projects
were seen during this research. This was one reason for the introduction
of NCW to encapsulate the in-house code built up over the years into a
single maintainable package. The pragmatic programming approach also
aids this.39 There are three principles to follow: version control, testing
and continuous integration. First, a collection of source ﬁles is no good to
anyone; documentation, compilation instructions and any dependencies are
required. Version control is a repository of source code (or any ﬁle) which
keeps a record of all the changes to a project. The repository’s ability to
compare and revert to older revisions is very useful, as well as the simple
fact that all the required ﬁles are in one place. Popular version control
programs are subversion40,41 and git42; both follow a diﬀerent methodology.
Second, how can one know what code is supposed to do? Documentation
is normally thin, rarely extensive. Unit tests provide the programmer with
some conﬁdence in the code, but third parties can view unit tests as sam-
ple code usage. Unit tests enable code veriﬁcation and validation. In Java
the unit test is written in a separate source ﬁle and tests public methods
within the class. Tests in Java are known as JUnit tests. Third, contin-
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uous integration allows repetitive deployment tasks to be automated and
performed by a schedule and on demand. CruiseControl is a popular open
source choice.43 Once conﬁgured it detects any change to one’s source con-
trol repository then checks out the latest code, builds it, running any tests
as well. Not only does this save the developer time performing extra steps
(which often would not be carried out), it can highlight errors very quickly;
from test failures to missing dependencies on the build machine. Compila-
tion is always simple on the developer’s machine. The clean build machine
is used to highlight hidden dependences. Both NCW and FBI follow these
three pillars of software development. In addition, CruiseControl can auto-
mate packaged installers using IzPack. IzPack is a Java based GUI wizard
installer.44 Once CruiseControl has compiled the basic source IzPack creates
an installer. CruiseControl also packages it ready for easy deployment on
Windows, Mac and Linux. After each source change everything is deleted
and built from scratch, ideally ending with one’s deployment ﬁles ready to
go, or an email highlighting the error and modiﬁcation to the source since
the last successful build. This is far quicker than a developer could do,
saving time and allowing others to access the compiled code easily.
1.5 High Performance Computing
To generate large numbers of QSAR models more than a single workstation
is required. For a combination of reasons including data set sizes and al-
gorithm complexity, model generation time is increasing. The use of High
Performance Computing (HPC) is prevalent within science already. Within
Chemistry, molecular dynamics and ab initio calculations are common tasks
for HPC. HPC clusters can readily generate large numbers of QSAR mod-
els. To take advantage of computational advances algorithms are being
written with parallel coding. The use of parallel programming standards
can reduce computation on multi-cores computers which are the de facto
21
standard now. Previously, HPC has utilised parallel computation across
physical computers. This requires rewriting your software and having a
cluster with suitable parallel connectivity. The latest parallel advances re-
late to the same hardware, not clusters. However, merging both forms of
parallelism is possible and advantageous. Universities and industry alike
both have HPC facilities available for researchers. HPC is dominated by
the Linux operating system. Most HPC codes were never written for Win-
dows. Scientiﬁc computing is ﬁrmly a task for Linux. Queuing systems
are available for HPC as many users will want access to the compute re-
source. Sun Grid Engine is a well known example. It enables users to
submit jobs to the queue and it will process them according to priority,
hardware requirements and resources available. Traditional HPC is carried
out on large, purpose built, homogeneous clusters. This typically represents
a large investment from the institution, but has deﬁned outcomes (in terms
of compute ability). More recently a diﬀerent model, Grid computing, has
become popular. Grid computing varies from HPC as it does not rely on
dedicated resources. The key concept of Grid computing is a dynamic pool
of resource that is constantly changing for various reasons. With this set
up queues are handled diﬀerently and rules are in place for when non dedi-
cated resource is being used. The appeal of Grid computing is the ease at
which the pool size can grow by utilising existing hardware. The standard
workstation today is more powerful than dedicated HPC cluster nodes only
a few years ago. However, after 5pm these workstations sit idle, wasting
electricity and CPU cycles. Grid computing enables you to tap into this
resource. From a cost perspective this is an attractive route to increase
total compute resources. Condor is a popular program to manage a grid
clusters. Grids are not bound by geographic location, unlike HPC which
tend to represent a physical set of hardware. BOINC, another grid sched-
uler, runs many public research projects on volunteer computers across the
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world. Using Condor one can achieve similar global pools.
Computational hardware and software develop at astonishing rates, and
continue to do so. In order to exploit these advances our scientiﬁc software
must make use of these developments. There is a cost with parallel or sim-
ilarly advanced coding paradigms - they are increasingly complex to write.
One requires a ﬁrm understanding of the base language before attempting
to parallelise code. In this respect one needs to be a more accomplished
programmer to fully leverage the resources available. Although challenging,
the return is impressive. GPUs (Graphical Processing Units), another form
of parallelism on GPUs opposed to CPUs can achieve speed improvements
of one hundred fold.
1.6 Summary
QSAR needs to remain in favour with cheminformaticians. This can be
achieved by using appropriate statistics that correctly represent the data
and exploiting the chemical insight within the model. Suitable statistics is
a matter of good practice and not using any one measure to determine how
useful a model is. The presence of readily available interpretation would be
desired by any modeller. Robust statistics and reliable interpretation will
lead to greater conﬁdence in models. This is not to say models are perfect
predictions, they are not. However, if the one has chemical insight available
and a measure of conﬁdence then an informed decision can be made based
on the data.
In the following chapters we will test various hypotheses. We will assess,
by means of multiple comparison statistics, if random forests oﬀer competi-
tive predictive ability to support vector machine using multiple data sets. In
order to assess multiple classiﬁers, data sets and parameters in a timely fash-
ion high performance computing schedulers will be employed. It is already
known that random forests are interpretable. However, the practicality of
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accessing this interpretation has received less attention. The volume of 100
trees makes manual interpretation unattractive. We will investigate tools
to assist in dealing with this number of trees. The TMACC descriptors
have demonstrated predictive ability. They are interpretable but this has
not been validated in detail. We will retrospectively test data sets to see if
the TMACC interpretation matches that reported in the literature.
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Chapter 2
Methods
2.1 Learning classifiers
While QSAR has a relatively long history for a computational method, mod-
ern QSAR borrows directly from the machine learning techniques of data
mining. Neural networks and SVM are two such examples. The goals of
QSAR and data mining do not overlap entirely. While both are concerned
with generating a model to explain an unknown relationship, only QSAR
has the secondary goal of model interpretation. The inner workings of a
model based on chemical insight are invaluable, more so than mining credit
card spending habits, for example. The ability to interpret is speciﬁc to
the model. Some are straightforward; others are not. This would not be
a primary concern when a new technique is designed. However, for use in
drug discovery it is tremendously useful. There has been lots of work inter-
preting learning classiﬁers, e.g. neural networks, that were not interpretable
originally.21 It is arguable that interpretation is more important than im-
provements in prediction accuracy. Next, the various learning classiﬁers
used in this thesis will be discussed.
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2.1.1 Decision tree
The decision tree,45 also known as recursive partitioning, is essentially a
collection of decision stumps. Each stump is a split of the instances available
according to the attribute with the greatest purity. The purity for a given
attribute is the fraction of correctly classiﬁed instances. In the full tree each
split results in two subsets of instances. Both of these are now split again on
the purest attribute. This continues recursively, until a stopping criterion
is met, typically a minimum number of instances. The splits are known as
branches, while the collection of classiﬁed instances is a leaf. The tree is a
collection of both. Afterwards a pruning algorithm is applied, which reduces
the tree to the core components. The result is typically smaller than the
original tree, which helps to reduce overﬁtting. Duplicate branches and/or
leaves can be removed during this process and the tree can have a more
lop-sided appearance. A decision tree modelling Lipinski-like rules46 can be
seen in Figure 2.1.
Figure 2.1: An example decision tree modelling Lipinski-like rules. Molecu-
lar weight (MW) should not exceed 350. The octanol-water partition coef-
ﬁcient (logP) should be below four. Hydrogen bond donors (HBD) should
not exceed ﬁve. Hydrogen bond acceptors (HBA) should not exceed eight.
Note the classiﬁcations of active or inactive refer to meeting Lipinski rules,
not molecular activity.
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Once a tree is built it can be used on external data to produce a classiﬁ-
cation and a set of rules determined by the path travelled through the tree.
More than two splits per branch is possible. In Weka20 only two splits per
branch are allowed. However, multi-classiﬁcation problems can be solved.
Due to the construction of the tree, the time to generate it can be predicted
in advance.
2.1.2 Ensemble methods
To improve the performance of single classiﬁers, ensemble or meta ap-
proaches have been developed. Of note are bagging, see section 2.1.3, boost-
ing, see section 2.1.4 and stacking, see section 2.1.5. The premise behind
the technique is that 100 experts will, on average, provide a better answer
than a single expert. If there are disagreements the majority and other
methods can be used to determine the overall ensemble answer. There has
been much research into how these techniques work.47–49 Some results have
proved diﬃcult to explain, for example adding random variance to bagging
will improve the performance. Boosting has been the subject of extensive
analysis and not until its close relation to additive learning became appar-
ent was it understood.50 Bagging and boosting are concerned with using
the same classiﬁers for the whole ensemble, whereas stacking can mix any
number of diﬀerent classiﬁers together. Both approaches work well, as one
would expect by repeating the same technique multiple times or combining
multiple results together. It should be noted that each replica is unique in
some fashion. In bagging diﬀerent data is used for each classiﬁer. Stacking
is also appealing, as there is no single silver bullet for the optimal classiﬁer.
It is widely accepted that one must try a selection of classiﬁers. However, as
a rule of thumb certain techniques such as SVM and random forest generally
perform well. There is always the exception, as demonstrated in Chapter 3,
where a single decision tree outperforms several more advanced techniques,
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including SVM and random forest.
The prediction error of an ensemble is related to the error of the indi-
vidual classiﬁers:
MSEEnsemble =
1
N
MSE (2.1)
where MSE is the average mean squared error, MSE of individual mem-
bers and N is the number of members in the ensemble. As the number
of members increases the theoretical error is smaller than that of a single
member.51 Increasing N indeﬁnitely will not yield constantly improving ac-
curacy; the improvement may become very small. In addition increasing
the ensemble size will increase compute time, which may be undesirable.
The error of an individual member can be expressed in bias and variance:
MSE = V ariance(θˆ) +Bias2(θˆ) (2.2)
where θˆ is a estimator of the quantity θ. Model bias decreases as model
variance increases. This would seem reasonable. As the model becomes
more complex, the bias towards any single instance will decrease. There
is a trade-oﬀ between these two functions. Ideally, both should be low.
However, as one adds data to reduce the bias, the variance will increase. The
ideal model will balance both functions, but still maintain good predictive
power and avoid overﬁtting. Ensembles achieve predictive improvement by
reducing the variance in their members and leaving the bias unaltered. By
taking advantage of the bias and variance trade-oﬀ the ensemble can obtain
a lower prediction error than any single member.
2.1.3 Bagging
While trees oﬀer relative straightforward interpretation, they are less ac-
curate than state-of-the-art techniques, such as SVM. Ensemble techniques
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such as bagging oﬀer improvements over a single classiﬁer. Bagging is a
simple, yet eﬀective approach. One creates n bags of the original data set
by sampling with replacement, thus allowing the same instance into the
same bag. With each of the n unique bags, one builds a model using any
chosen classiﬁer, e.g. a decision tree. For each instance, there are n predic-
tions and a majority vote decides the overall classiﬁcation. One drawback
of meta techniques is the increase in model generation time. This exam-
ple takes n times longer than a single tree, but will build a more predictive
model. This is an example of Occam’s razor,52 where one must balance per-
formance with accuracy. Bagging lends itself to parallelism via the many
methods now available in computer science, such as threading and grid
computing. Bagging is depicted in Figure 2.2.
Figure 2.2: Overview of bagging. The training data set is used to generate
ten re-sampled data sets known as bags. Each will be unique. A classiﬁer
is built for each bag. Diﬀerent data ensures diﬀerent models. A majority
vote across all classiﬁers determines the ensemble prediction. Ten bags are
for depiction purposes. Breiman used 50 in his original study, but found a
lower number, could be optimal.53
2.1.4 Boosting
Boosting is a technique developed after bagging. It is widely reported to
outperform bagging.54 It works diﬀerently to bagging. A model is built
using a chosen classiﬁer. Each instance is assigned a weight depending on
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how hard it was to classify correctly. Subsequent iterations involve improv-
ing the existing model by focussing on the instances poorly predicted in
the previous iteration. With each iteration the model improves across the
data set. There are various ﬂavours of boosting, but all follow this general
premise. Freund and Schapire were the authors of the original work known
as AdaBoost.55–57. Weak learners are used in boosting.58 Weak learners are
simple learning methods. The simplest decision tree is a decision stump,
just one split. Boosting is very eﬀective at improving the performance of
decision stumps. Boosting does not work when the base learning is already
successful at predicting the data as there is little or no error to optimise.
Many comparison studies have focussed on bagging and boosting. Work by
Dietterich shows that with little classiﬁcation noise boosting outperforms
bagging. However, when substantial noise is present bagging is superior.47
Any classiﬁer can be boosted, but it is not always feasible, as is the case
with SVM. Diao et al. used only important instances, as determined by
active learning, to be included in the training data.59
2.1.5 Stacking
Stacking is another ensemble method.60,61 Unlike bagging and boosting it
is not restricted to using only one classiﬁer for model building. Instead
a selection of classiﬁers can be used in order to beneﬁt from the diﬀerent
learning schemes. The overall classiﬁcation reﬂects the combined predictions
of classiﬁers. This often leads to better performance than a single classiﬁer.
2.1.6 Random forest
Random forest combines bagging and the random subspace method for de-
cision forests.62 The trees in a random forest diﬀer to those previously de-
scribed. First, only a random subset of attributes is available at each split
point to determine purity, unlike all attributes in a typical tree. This can
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be viewed as built-in feature selection, even though attributes available are
randomly selected. Second, no pruning takes place. Third, in Weka’s im-
plementation there is no stopping criterion, leading to large, overgrown and
overﬁtted trees. In later versions of Weka a maximum tree depth option
was introduced allowing some degree of control over tree size. The result
of these changes leads to a tree that is substantially larger than using the
regular decision tree algorithm, even on the same data set. The tree is ar-
guably overﬁt as the terminal leaves contain only a single instance. The lack
of pruning leads to a very bushy structure. The size reduces the usefulness
of the tree, as it is more complex to interpret.
Random forest is essentially bagging using decision trees with the mod-
iﬁed trees. A random forest does outperform bagging with decision trees,
see Chapter 3. The increased size of the trees in combination with the ran-
dom availability of attributes is behind its improved predictive power. A
forest construction is depicted in Figure 2.3. Multiple implementations of
random forest are now available.63–66 All are based on an ensemble of trees.
Brieman’s forest67 is perhaps the most well known and used.
Figure 2.3: Overview of a random forest. Bootstrap samples are modelled
using individual trees. The overall classiﬁcation is based on a majority vote
by the trees. The tree construction varies from standard decision trees and
hence this is not bagging with decision trees.
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2.1.7 Support Vector Machine
SVMs are not bioinspired, in contrast to trees or neural networks. While
SVMs achieve excellent predictive power, they are not simple to interpret,
and little work has been done in this area.68 They are popular in a variety of
disciplines as they perform well on various data sets. The drawback of this
method is the model build time, due to the quadratic programming step of
the algorithm for building a SVM. By nature they avoid local minima, thus
aiding predictive power. Like most classiﬁers, researchers have modiﬁed
SVMs to improve them. Most of this work has been focussed on the kernel,
either creating new or modifying the common radial basis function (RBF)
or Polynomial kernels.
Vapnik is credited with the original work on SVMs.69 SVMs work eﬀec-
tively on both linear and non-linear problems. The SVM creates a hyper-
plane to split the data as accurately as possible, as shown in Figure 2.4.
This is not a simple linear separation as by use of a kernel-trick the SVM
transforms the feature space of descriptors. The linear hyperplane actually
represents a nonlinear relationship of the data. This transformation is one
of the problems of interpreting the model. Each kernel produces a diﬀerent
transformed feature space and thus several should be applied to ﬁnd the op-
timal kernel. In addition to selecting the most appropriate kernel there are
various other parameters that should be optimised. Some parameters aﬀect
the kernel; others do not. Non kernel speciﬁc parameters of importance are
the complexity constant and ǫ. The complexity constant controls the toler-
ation of misclassiﬁed instances, the higher the value the fewer misclassiﬁed
instances are permitted. ǫ controls the round oﬀ value. Both these param-
eters can greatly aﬀect the model generated. The SVM implementation in
Weka uses sequential minimal optimization variant of SVM to reduce the
time consuming quadratic programming step.70,71
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Figure 2.4: Separating hyperplane of the Support Vector Machine that max-
imizes the margin between two sets of perfectly separable objects, repre-
sented as circles and squares. (A) Optimal hyperplane that perfectly sepa-
rates the two classes of objects. (B) Optimal soft margin hyperplane which
tolerates some points (unﬁlled square and circle) on the wrong side of the
appropriate margin plane. Reproduced with permission from Jorissen, R.
N.; Gilson, M. K. Virtual Screening of Molecular Databases Using a Sup-
port Vector Machine. J. Chem. Inf. Model. 2005, 45, 549-561 Copyright
2005 American Chemical Society
2.1.8 Partial Least Squares
PLS72 is the more advanced version of Principal Component Regression
(PCR). PCR is concerned with explaining the variation in the dependent
variable. PLS improves PCR by taking both the dependent and independent
variables into account to explain the variation. PLS is a popular technique
in both cheminformatics and chemometrics. PLS produces an equation
which explains the dependent variable in terms of latent variables. These
latent variables are the combination of the independent variables with a
weighting coeﬃcient. The dependent variable, y, can be written as:
y = a1t1 + a2t2 + a3t3 + ...antn (2.3)
where an are coeﬃcients of the latent variables, tn. tn is deﬁned as
tn = bi1x1 + bi2x2 + ...bipxp (2.4)
where xp are the independent variables.
33
Each latent variable is orthogonal to each other, providing maximum
variation from the previous. The maximum number of latent variables is
the lower of the number of variables or instances. Typically, one will only
use a handful of the total latent variables. The coeﬃcients, an, are of
interest as they eﬀectively weight or select the important features for the
model. NCW uses these coeﬃcients to help identify what partial activity
each atom provides when using the TMACC descriptors.
2.2 Model statistics
There are various statistics to assess the predictive performance of a model.
Classiﬁcation and regression tasks require diﬀerent statistics. As we deal
with both, both are presented here. The general paradigm for creating a
model is to select a training set to build the model upon. That model
is then used to predict unseen data from a test set. For techniques which
require parameter optimisation, one may tune the model on a third, unseen,
validation set, therefore giving the model new data at each stage. The
abundance of data can be a luxury not aﬀorded to all. Cross-validation can
be used to assess the model by splitting the data in multiple training and
test sets. Even if suﬃcient data are available, the statistics produced from
cross validation are commonly used to compare models.
2.2.1 Classification
The initial statistics from a classiﬁcation experiment are the accuracy of the
classiﬁcations. This leads to four numbers per class: true positive (TP ),
false positive (FP ), true negative (TP ) and false negative (FN). These four
values are found in a confusion matrix. The number of classes determines
the size of the matrix. A general confusion matrix is shown in Table 2.1.
Knowing the incorrect predictions is perhaps more important than knowing
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Actual
Active Inactive
Predicted
Active TP FP
Inactive FN TN
Table 2.1: A general confusion matrix
what was correct. It is useful to see what instances proved a challenge for
the model to classify. A single statistic of use is the percentage of correctly
classiﬁed instances. However, this only reports the correct and incorrect
percentages, it does not take into account the four possible results (TP ,
FP , TP , FN). This limitation does not apply to the Matthews correlation
coeﬃcient,73 which takes all four into account, see Equation 2.5. Arguably
the percentage of classiﬁed instances is an inferior statistic compared to the
Matthews correlation coeﬃcient.
MCC =
TP × TN − FP × FN√
(TP + FP ) (TP + FN) (TN + FP ) (TN + FN)
(2.5)
The value represents a perfect prediction for +1, average random for 0
and an inverse prediction for -1. A limitation of the MCC is that it only
applies to binary classiﬁcation. For a greater number of classes one can use
the Kappa coeﬃcient. Fleiss’ Kappa74 not Cohen’s Kappa75 is used, as the
latter is for two classes only.
κ =
P¯ − P¯e
1− P¯e
(2.6)
where 1−P¯e is the degree of agreement attainable above chance. P¯−P¯e is the
degree of agreement actually achieved above chance. Complete agreement
gives κ of one. When there is no agreement κ is below zero. P¯ is the mean
of Pi and P¯e requires Pj. Pj, the proportion of all assignments which were
to the j -th category, is deﬁned as:
35
pj =
1
Nn
N∑
i=1
nij, 1 =
1
n
k∑
j=1
nij (2.7)
where N is the total subjects, n the number of ratings per subjects and k be
the number of categories. nij represents the number of raters who assigned
the i -th subject to the j -th category. Pi, is the extent to which raters agree
for the i -th subject:
Pi =
1
n(n− 1)
k∑
j=1
nij(nij − 1) (2.8)
=
1
n(n− 1)
k∑
j=1
(n2ij − nij) (2.9)
=
1
n(n− 1)[(
k∑
j=1
n2ij)− (n)] (2.10)
We calculate P¯ and P¯e to complete the formula for κ:
P¯ =
1
N
N∑
i=1
Pi (2.11)
=
1
Nn(n− 1)(
N∑
i=1
k∑
j=1
n2ij −Nn) (2.12)
P¯e =
k∑
j=1
p2j (2.13)
2.2.2 Regression
The correlation coeﬃcient, r2, represents the proportion of the variation
within the model of the predicted values against the observed. It is a useful
single value representation of the quality of the model. Several quantities
can be calculated which lead to r2:
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Total Sum of Squares: TSS =
N∑
n=i
(yn − yˆ)2 (2.14)
Explained Sum of Squares: ESS =
N∑
n=i
(ycalc,n − yˆ)2 (2.15)
Residual Sum of Squares: RSS =
N∑
n=i
(yn − ycalc,n)2 (2.16)
where N is the total number of molecules in the data set, n is the current
molecule, yn is the observed value and ycalc,n is the predicted value for
molecule n. These three quantities are related as follows:
TSS = ESS +RSS (2.17)
Therefore, there are several ways to calculate r2:
r2 =
ESS
TSS
≡ TSS −RSS
TSS
≡ 1− RSS
TSS
(2.18)
The r2 applies to the original model. Cross-validated data (see the
next section) produce q2, the cross-validated r2. q2 is more interesting,
as it measures predictive ability, opposed to how well all the data were
modelled. q2 is calculated using PRESS, which is analogous to RSS, except
the predicted, not observed value is used:
Predictive Residual Sum of Squares: PRESS =
N∑
n=i
(yi − ypred,i)2 (2.19)
q2 = 1− PRESS
N∑
n=1
(yi − y¯)2
(2.20)
Note that yˆ becomes the mean y¯ for q2, as the mean for the appropriate
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cross-validation group should be used, as opposed to the mean for the whole
data set (which is not an accurate representation when cross-validating).
However, both r2 and q2 can be misleading. While a value of 0.75
may sound good, the actual data could reﬂect several large outliers, rather
than good overall correlation. Therefore, any one single statistic should
not be used to judge a model, but several in conjunction to avoid potential
overconﬁdence in a model. In addition, even a seasoned modeller should
visualise his/her predicted and observed data.
Measuring error for numeric predictions is more involved than simply
a count or percentage of incorrectly classiﬁed instances. Two common er-
ror statistics are mean absolute error (MAE) and root mean-squared error
(RMSE). Using the same notation as earlier, MAE is given as:
MAE =
| ycalc,1 − y1 | +...+ | ycalc,n − yn |
N
(2.21)
RMSE is deﬁned as:
RMSE =
√
(ycalc,1 − y1)2 + ...+ (ycalc,n − yn)2
N
(2.22)
2.2.3 Cross-validation
Cross-validation allows one to measure the predictive ability of a model.
This can be done for extra statistics or when insuﬃcient data are available
to populate a test set. The training data are split into n folds; ﬁve or ten
are commonly used. Each fold should be stratiﬁed, that is they contain a
representative sample of the data set.76 Nine folds are combined to form
the training data on which the model is built; the remaining fold is used to
test upon. This is repeated so each fold is the test set only once. All results
are averaged to give the ﬁnal predictive measure.
It could be argued that leave-one-out (LOO) cross-validation is the op-
timal method as it gives the most available data for training. The model is
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only as good as the training data provided to it. So one should maximise
the amount of data where possible. The downside of LOO is N models are
required. For large data sets and/or slow learning techniques, this can lead
to an unacceptable compute time. Experiments in Chapter 3 did run for a
week using ten-fold cross-validation, which would not be practical for most
purposes.
2.3 Nonparametric Multiple-Comparison Sta-
tistical Tests
Traditional pairwise statistics (such as the t-test) are inappropriate when
making multiple comparisons. Here, we present a two-stage, nonparamet-
ric approach. The ﬁrst test that should be applied is to determine if any
signiﬁcant diﬀerences between the classiﬁers can be detected. For this, the
Friedman test is used.77,78 The null hypothesis for the Friedman test is that
there is no diﬀerence between any of the classiﬁers. If the null hypothesis is
rejected, it does not determine which groups are diﬀerent from each other;
for this, a separate test is required. However, the Friedman test should be
applied ﬁrst, to determine if further analysis is justiﬁed. In the following, we
shall assume that there are k classiﬁers and N data sets, and that all clas-
siﬁers have been applied to all data sets, in each case yielding a real-valued
measure of the performance of the classiﬁer. In the work discussed in this
thesis, we have used percentage accuracy, but other measures, such as the
area under the receiver operating characteristic curve, are also possible.79
The Friedman test proceeds as follows. For each data set, the performances
of the classiﬁers are ranked, in ascending order; that is, the best performing
classiﬁer has rank k, the next best rank k − 1, and so on. Then, for each
classiﬁer j, the mean average rank across all data sets, R¯j, is calculated.
The individual rank of a given classiﬁer, j, and data set, i, is denoted by
39
rij.
R¯j =
∑
i
rij
k
(2.23)
The Friedman statistic, χ2F , is then calculated as
χ2F =
12N
k(k + 1)
[∑
j
R¯2j −
k(k + 1)2
4
]
(2.24)
For suﬃciently large k and N (Demsˇar80 suggests k > 5 and N > 10),
the Friedman statistic is distributed according to the χ-squared statistic,
χ2, with k − 1 degrees of freedom. Critical values of χ2F for smaller values
of k and N are provided in ref81. In the event of tied ranks (i.e., two or
more classiﬁers giving identical performances on a data set), a correction
factor may be applied to χ2F . One such correction (used, for example, in
the statistical package R82) where the sum of the ranks across all data sets,
Rj, is
Rj =
∑
i
rij (2.25)
and the correction statistic is
χ2C =
12
∑
j
{[
Rj − n (k + 1)
2
]2}
nk (k + 1)− C (2.26)
where C, the correction factor, is
C =
m∑
i=1
(
t3i − ti
)
m
(2.27)
m is the number of groups of tied ranks for a classiﬁer, and ti is the number
of ties in the ith tied group. Equation 2.26 without the correction factor, C,
gives the same result as equation 2.24. Iman and Davenport83 demonstrated
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that the Friedman statistic was too conservative and suggested the following
improvement:
FF =
(N − 1)χ2F
N (k − 1)− χ2F
(2.28)
This is distributed according to the F distribution with k − 1 and
(k − 1)(N − 1) degrees of freedom. If the null hypothesis is rejected, then
statistically signiﬁcant diﬀerences between the classiﬁers are present. The
Nemenyi test84 can be applied to determine these diﬀerences in a pair-
wise fashion. To compare classiﬁers a and b, the diﬀerence in mean ranks,
R¯a − R¯b, is calculated. This value is compared to the critical diﬀerence,
CD:
CD = q′α
√
k (k + 1)
6N
(2.29)
where the corrected q statistic, q′α, is given by
q′α =
qα√
2
(2.30)
qα is the critical value of the “Studentized range” statistic at a given level
of signiﬁcance, α. Tables of the critical values of the q distribution can be
found in statistical packages such as R and elsewhere.81 If the diﬀerence
between the average ranks is larger than CD, then the diﬀerence between
the classiﬁers is signiﬁcantly diﬀerent at the speciﬁed value of α. Demsˇar
has discussed multiple classiﬁer comparisons in greater detail.80
2.4 Topological maximum cross correlation
descriptors
James Melville is the author of the TMACC descriptors
Topological maximum cross correlation (TMACC) descriptors85 are 2D
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descriptors for use in interpretive QSAR. They were inspired by the grid-
independent descriptors (GRIND).86 The GRIND descriptors, unlike TMACC,
are 3D descriptors. TMACC descriptors vary in two ways. We replace force
ﬁeld interactions measured from a grid with atomic physicochemical values
and the 3D distance between points is replaced with the 2D topological
bond distance. TMACC descriptors were validated against HQSAR,87 as
this 2D method is seen as comparable to the 3D QSAR techniques CoMFA
and CoMSIA.88 In addition, a large corporate study found HQSAR per-
formed best over 1000 data sets.89 TMACC perform competitively against
HQSAR, yielding higher cross-validated q2 in ﬁve out of eight data sets.85
Therefore, we are conﬁdent these descriptors can produce predictive mod-
els. However, we now wish to validate their interpretative ability. This is
only brieﬂy examined in the original work. We perform a more extensive
validation and have built further tools to enable this.
The TMACC descriptors encode four atomic properties. Electrostatics
are provided by Gasteiger partial charges.90 Steric and polarisability are
provided by Crippen-Wildman molar refractivity.91 Hydrophobicity is from
Crippen-Wildman logP.91 Finally solubility and solvation phenomena are
calculated from Xu et al. logS.92 Solubility can be both a descriptor and
prediction target. For example, the TMACC descriptors are used with
the solubility challenge data set in Chapter 5. The TMACC descriptors
individually only calculate predicted solubility for a given pair of atoms, a
contribution of solubility, not the whole compound. It is not solubility but
Xu parameters representing solubility and hence solvation phenomena. We
are not assigning a solubility value to a pair of atoms independent of the
rest of the molecule. For the solubility challenge in particular we wanted to
test how accurate TMACC descriptors are, given they include this solubility
property. The method developed by Xu uses atom typing rules, determined
by 76 SMARTS rules and two correction factors, hydrophobic carbon and
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squared molecular weight. Multiple linear regression was used to determine
the contribution of each atom type.
The values of each property are rescaled between -1 and +1, except logS,
which only has positive values. The absolute negative and positive values
were used to rescale to -1 and +1 respectively. For the partial charges the
absolute values were determined from the fragmentlike subset of the ZINC
database,93 consisting of 49134 molecules. The calculations were carried out
with Open Babel 2.0.0.94,95 By having a negative and positive range they
can be treated separately. This gives seven total atomic properties: positive
charge, negative charge, positive logP, negative logP, positive molar refrac-
tivity, negative molar refractivity and logS . From these seven, 28 possible
combinations of pairs are possible, and they are the base descriptors. For
each pair of atoms in the molecule, all 28 descriptors values are calculated.
The descriptor is additionally encoded with the topological bond distance.
Therefore, the total number of descriptors for the dataset is 28 multiplied by
the maximum topological bond distance. For QSAR datasets, this value is
typically under a thousand. For a molecule with topological bond distance
of ten, e.g. aspirin (Figure 2.5) one block of descriptors would be:
Maximum:ScaledAtomPartialPositiveCharge:ScaledAtomPartialPositiveLogP:0
Maximum:ScaledAtomPartialPositiveCharge:ScaledAtomPartialPositiveLogP:1
Maximum:ScaledAtomPartialPositiveCharge:ScaledAtomPartialPositiveLogP:2
Maximum:ScaledAtomPartialPositiveCharge:ScaledAtomPartialPositiveLogP:3
Maximum:ScaledAtomPartialPositiveCharge:ScaledAtomPartialPositiveLogP:4
Maximum:ScaledAtomPartialPositiveCharge:ScaledAtomPartialPositiveLogP:5
Maximum:ScaledAtomPartialPositiveCharge:ScaledAtomPartialPositiveLogP:6
Maximum:ScaledAtomPartialPositiveCharge:ScaledAtomPartialPositiveLogP:7
Maximum:ScaledAtomPartialPositiveCharge:ScaledAtomPartialPositiveLogP:8
Maximum:ScaledAtomPartialPositiveCharge:ScaledAtomPartialPositiveLogP:9
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Maximum:ScaledAtomPartialPositiveCharge:ScaledAtomPartialPositiveLogP:10
Figure 2.5: Aspirin. TMACC descriptors are based on topological distances.
The maximum distance here is 11 between the two carbonyl oxygens. There
is more than one route to reach 11. The topological distance includes a zero
term.
Here the descriptor positive charge-positive logP is shown, with 11 po-
tential bond distances (we include a distance term of zero, the value with
itself). The total number of descriptors for aspirin would be 308; that is
28 TMACC descriptors multiplied by 11 maximum topological bond dis-
tances. There are multiple pairs of atoms which are ﬁve bonds apart. The
TMACC only records the maximum value reported across the molecule.
However, other pairs that register a value are recorded for the purpose of
interpretation, and used later.
The equation for calculating an autocorelation descriptor, xac, is
xac(p, d) =
∑
pipj (2.31)
where p is a property, e.g. negative partial charge and d is the topologi-
cal bond distance between atoms i and j. The sum is over all atom pairs
separated by distance d. The TMACC descriptors alter this equation in
three ways. First, each atomic property that has a negative and positive
value is treated as two separate properties. Second, we calculate cross-
correlation in addition to the autocorrelation. We allow the property of
atom i to vary from atom j, allowing positive charge-positive charge; nega-
44
tive charge-negative charge and positive charge-negative charge. Third, like
the GRIND descriptors, we only keep the maximum value calculated for
any given distance. The TMACC equation is, therefore
xtmacc(p, d, q) = max(piqj, qipj) (2.32)
where q is the property of the second atom. There are two terms to consider
for each atom pair, because when p 6= q, qjpi 6= pjqi.
While the TMACC descriptors are interpretable in nature, used with
PLS they become more powerful than a simple frequency of fragments.
FGRAM details the atoms which contribute to each descriptor. For example
the descriptor positive charge-positive charge with a bond distance of two
has a value of 0.3. Together with the PLS coeﬃcients, the FGRAM allows
an activity contribution level to be assigned to each atom.
TMACC and FGRAM generated were originally available only as a
Java command-line application. To assess the interpretative abilities of
the method more fully, it would be useful and obviate time consuming
atom labelling if this could be automated. NCW - Nottingham Chemin-
formatics Workbench was created for this purpose. It is a GUI designed
to accommodate in-house code, primarily TMACC. It oﬀers little beneﬁt
over the command-line for generating the original descriptors, but it has
ChemAxon’s Marvin96 embedded, giving the user the ability to draw and
edit molecules. NCW can generate models, interpret the descriptors using
the PLS model, generated through Weka, analyse the results and display
the dataset with a colour coding scheme in Marvin.
The PLS regression produces a model in the format
(desc1C × desc1SE) + (desc2C × desc2SE) + (descxC × descxSE) (2.33)
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where descxC is the coeﬃcient for descx and descxSE is the standard error
for descx. Not all descriptors present in the dataset will be in the model.
For each descriptor present, one calculates the activity contribution, AC
AC = TMACC × PLSC (2.34)
where TMACC is the TMACC value for this descriptor and PLSC is the co-
eﬃcient from the PLS for this descriptor. From the corresponding FGRAM
one extracts the all atom pairs for descriptor i. All pair weights must be
normalised to sum to 1.0. For each pair the pair activity contribution, PAC
is
PAC = wpair × AC (2.35)
where wpair is the normalised pair weight. This enables one to calculate the
contribution from each atom
atomcontribx =
PAC
2
(2.36)
and
atomcontriby =
PAC
2
(2.37)
It is assumed that each atom contributes equally to the overall contri-
bution. This method is repeated for all descriptors present in the model
and on each molecule in the dataset. For each molecule, one sums the indi-
vidual atom contributions to give an overall contribution. One can take all
atom contributions over the whole dataset, sort into ascending order and
split into ﬁve equally sized groups. The ﬁrst group represents very negative
activity contribution, the last very positive activity contribution.
NCW has the machinery to generate the TMACC and FGRAM, using
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Impact on activity Colour
Very negative Red
Negative Orange
Neutral Yellow
Positive Green
Very positive Blue
Table 2.2: Colour codes used in TMACC interpretation
Melville’s code.85 The code released with the original publication is taken
directly, as obtainable on our website, http://comp.chem.nottingham.ac.
uk/download/tmacc, and modiﬁed to enable NCW to access to the output
programmatically. All further analysis is performed by new code in NCW.
PLS is applied and the model used to determine the partial activity con-
tribution from each atom. This value is converted to the one of ﬁve labels,
represented by colour, then drawn and coloured by Marvin. Table 2.2 de-
tails the colour scheme implemented. Figure 2.6 depicts a sample ACE
compound after complete processing through NCW.
Figure 2.6: A molecule from the ACE dataset in NCW, after the each atom
has been assigned an activity contribution by colour
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This chapter has highlighted the numerous methods which will be used
throughout the following chapters. Many concepts are central to Computer
Science, speciﬁcally the ﬁelds of Data Mining and Machine Learning. This
emphasis demonstrates the cross-disciplinary nature of this research, which
is paramount in producing new novel approaches. Cheminformatics, like
Computational Chemistry, is entwined with Computer Science. The next
chapter compares a number of classiﬁers. Relative performance of multiple
classiﬁers over multiple data sets is demonstrated using appropriate statis-
tical tests.
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Chapter 3
Contemporary QSAR
classifiers compared
This chapter is a reproduction of the peer-reviewed article.97
3.1 Abstract
We present a comparative assessment of several state-of-the-art machine
learning tools for mining drug data, including support vector machines
(SVMs) and the ensemble decision tree methods boosting, bagging, and
random forest, using eight data sets and two sets of descriptors. We demon-
strate, by rigorous multiple comparison statistical tests, that these tech-
niques can provide consistent improvements in predictive performance over
single decision trees. However, within these methods, there is no clearly
best-performing algorithm. This motivates a more in-depth investigation
into the properties of random forests. We identify a set of parameters for
the random forest that provide optimal performance across all the studied
data sets. Additionally, the tree ensemble structure of the forest may pro-
vide an interpretable model, a considerable advantage over SVMs. We test
this possibility and compare it with standard decision tree models.
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3.2 Introduction
The pharmaceutical industry needs to address the increasing cost and time
for drug development,98,99 and in silico lead discovery and lead optimization
are becoming increasingly important means to achieve this. Lead optimiza-
tion often involves quantitative structure-activity relationships (QSARs),15,100
which focus on predicting the biological activity of a compound from a vec-
torial representation of molecular structure. In the past few years, the
computer science community has developed new machine learning algo-
rithms20 suitable for QSAR development. One success story is the support
vector machine (SVM),101 which has featured regularly in the bioinformat-
ics102–104 and cheminformatics literature.105–108 Some studies have suggested
that SVMs show improvement over neural networks for classiﬁcation and
QSAR.109–111 The advantages oﬀered by SVMs are robust predictions even
with sparse and noisy data, because the formulation of the SVM solution
ensures that there is only one minimum, thus avoiding the problems of
premature convergence found with neural networks.
Another popular machine learning method is the decision tree, also
known as recursive partitioning.45,112 By partitioning the data into disjoint
groups, decision trees produce nonlinear models that are interpretable, a
valuable property of any statistical machine learning method when applied
to QSAR studies.113,114 A further improvement in the accuracy of decision
tree predictions was achieved with the introduction of ensemble methods,
where multiple trees are constructed and the outputs combined to produce
a ﬁnal prediction.48,115 The most popular of the ensemble techniques are
boosting56 and bagging;53 other variants are known as decision forests62,64
and random forests.67 We note that ensembles are not restricted to consist
only of decision trees; other algorithms used for base learners include linear
discriminant analysis,116 neural networks,117,118 and partial least-squares
regression.119,120
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Given the increasingly widespread adoption of these advanced machine
learning techniques in chemometric121–123 and cheminformatics ﬁelds,54,117,124
it is timely to carry out rigorous assessment of these algorithms. Recently,
Plewczynski et al. presented a comparison of some machine learning meth-
ods for virtual screening.125 The focus of our study diﬀers in several as-
pects. First, we seek to apply rigorous statistical tests to our results. It
is still rare when evaluating classiﬁers in cheminformatics to make use of
tests of statistical signiﬁcance. However, there is a further caveat: in wide-
scale comparisons of learning algorithms, it is not suﬃcient to use pair-wise
statistical comparison tests, such as the paired t-test. Therefore, we make
use of nonparametric statistical tests that are suitable for multiple compar-
isons. Second, apart from predictive ability, there are other requirements
that make such tools valuable for mining chemical data. First, it is desirable
to avoid having to manipulate multiple parameters to ﬁnd the optimal per-
formance for an algorithm. The requirement to tweak such parameters can
lead to overﬁtting,126 giving a false picture of predictivity, as well as being
potentially time-consuming. Therefore, techniques with few parameters, or
for which a widely applicable set of parameters can be obtained, are de-
sirable. Second, an interpretable model is extremely valuable in extracting
structure-activity relationships and relating the predictions of algorithms
to physicochemical principles. SVMs are diﬃcult to interpret; ensemble
methods using decision trees may therefore have an advantage in this area.
The translation of individual tree-based methods into classiﬁcation rules is
already widely documented,11,127–130 but there have been only limited at-
tempts to extend the interpretation to ensembles.54,131 We investigate and
highlight some challenges in this endeavour, compared to a single decision
tree.
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3.3 Methods
Learning Algorithms. For generating classiﬁers, we used the Java ma-
chine learning workbench Weka version 3.4.7.20 Details of the algorithms we
use in this study have been described in detail previously.20 However, we
provide a brief introduction. SVMs are considered to provide state-of-the-
art classiﬁcation performance, and we therefore use them as a benchmark
to compare the performance of the ensemble methods, which make use of
decision trees. SVMs create a separating hyperplane in the descriptor space
of the training data, and molecules are classiﬁed on the basis of what side
of the hyperplane they are located.101 The advantage of the SVM is that,
by use of the so-called kernel trick, the distance between a molecule and the
hyperplane can be calculated in a transformed (nonlinear) feature space,
but without requiring the explicit transformation of the original descrip-
tors. A variety of kernels have been suggested, such as the polynomial
and radial basis function (RBF). A polynomial kernel with an exponent of
one reduces to the case of the linear SVM. Finding the optimal separating
hyperplane requires the use of quadratic programming. As this can be time-
consuming, we make use of the sequential minimal optimization71 (SMO)
variant of SVMs, which provides an approximation to the quadratic pro-
gramming step. SVMs come with a range of parameters: those that aﬀect
the overall SVM and those speciﬁc to the kernel. Even with the speedup
associated with SMO, a full search of the entire parameter space would be
prohibitively time-consuming, and it is necessary to focus on the parame-
ters that are most crucial to the performance of the algorithm, such as the
choice of kernel.132 We tune one kernel-independent parameter, two diﬀerent
kernels, and one kernel-speciﬁc parameter. The two kernels we investigate
are the polynomial and RBF. In addition, the complexity constant is varied
from the default 1 to 0.05 and 50. For each kernel, one kernel-speciﬁc pa-
rameter is altered, the exponent for the polynomial (default 1, altered to 2
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and 3) and γ, the RBF width (default 0.01, altered to 0.001 and 0.1). The
complexity constant controls the tolerance of misclassiﬁed molecules: the
higher the value, the greater the importance of reducing misclassiﬁcations
in the training model.
Decision trees recursively partition molecules into a series of disjoint sets
or nodes, starting from a pool of all training data (called the root node).
The node into which a molecule is placed is dependent on a threshold value
of a particular descriptor (a branching rule). When a node is reached for
which no branching rule is deﬁned (a terminal node, or “leaf”), the molecule
is classiﬁed, on the basis of the properties of the molecules with which it
shares the node. This is normally achieved via majority vote. Each path
through the tree from the root to a leaf can be extracted and represented as
a classiﬁcation rule, enabling interpretations to be made, which accounts for
the popularity of this technique.11,127–130 The tree-building algorithm used
in this study is J48, a Java implementation of the C4.5 algorithm due to
Quinlan.112 A feature of the J48 algorithm is that it “prunes” leaves that do
not contribute greatly to the predictive accuracy of the tree. This creates
smaller trees, which may be more resistant to overﬁtting.
While decision trees have the advantage of being interpretable, their
predictive abilities are normally inferior to that of more advanced tech-
niques. Ensemble techniques attempt to compensate for the weakness of an
individual tree by combining the predictions of multiple trees. The key to
ensemble methods is therefore producing diverse selections of trees. This is
normally achieved by training each tree on a diﬀerent subset of the data.
This can involve subsampling both molecules and descriptors. A commonly
used technique is the bootstrap,133 which samples the molecules with re-
placement. The resulting bootstrap sample is likely to contain duplicate
molecules, while some of the original training data may not appear at all.
The simplest ensemble method we study is bagging.53 Here, the ensemble
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is formed by simply repeatedly training trees on bootstrap samples of the
original data. Classiﬁcation of new molecules is by majority voting across
all trees. Boosting57 also uses bootstrap samples. However, the accuracy
of the previous tree is used to bias the selection of molecules for the next
sample, with poorly predicted molecules being given a greater chance of
selection (or a larger weight) so that the next tree will focus on these more
diﬃcult cases. Again, voting is used to classify new molecules, but the vote
is weighted to give more inﬂuence to trees with greater accuracy. Boosting
is widely considered to be more accurate than bagging.134 In our experi-
ments we use the AdaBoostM1 algorithm.56 A random forest67 is similar
to bagging, except that, as well as sampling training molecules randomly,
only small subsets of descriptors are used to build each tree. Like bagging,
classiﬁcation is by majority vote. For bagging and boosting, we use the J48
algorithm to build the base decision tree classiﬁers. For random forest, we
use random trees as a base classiﬁer rather than trees built with J48. The
main diﬀerence between J48 trees and random trees is that no pruning is
carried out for random trees.
Data Sets. Eight data sets (Table 3.1) have been taken from the study
of Sutherland et el.:88 (1) a set of angiotensin-converting enzyme (ACE)
inhibitors originally used for comparative molecular ﬁeld analysis (CoMFA)
modelling;135 (2) a set of acetyl-cholinesterase (AchE) inhibitors, a subset
of which was used in CoMFA studies;136 (3) a set of ligands for the benzodi-
azepine receptor (BZR) also used for validating several QSAR methods;137
(4) a set of cyclooxygenase-2 (COX2) inhibitors - a subset was used in
CoMFA studies;138 (5) a set of dihydrofolate reductase (DHFR) inhibitors,
which were also used for comparative molecular similarity indices and analy-
sis modeling;139 (6) a set of glycogen phosphorylase b (GPB) inhibitors;140
(7) a set of thermolysin (THER) inhibitors;30 and (8) a set of thrombin
(THR) inhibitors.141
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Our study focuses on classiﬁcation of activity, either active or inac-
tive. The original data sets provide continuous numerical values for activity
(pIC50 for the ﬁrst ﬁve data sets and pKi for the last three); each data set
shows a uniform distribution of activity values. Therefore, the median ac-
tivity value was used as a threshold between active or inactive compounds
to create a 50/50 split of active/inactive observations. Balancing the data
set in this way simpliﬁes the validation of the classiﬁers and allows the use
of percentage classiﬁcation accuracy as a measure of classiﬁer performance.
However, the arbitrary split between active and inactive classes will actually
make the problem harder for the classiﬁers. The compounds which fall near
the median should be excluded from the model to the create a real split
between classes.
To create QSARs, descriptors of the molecules are required. We use
the 2.5D descriptors generated by Sutherland et al.88 using Cerius2.142 In
addition, linear fragment descriptors for these data sets were computed.
For each data set, descriptors containing data on the atomic number, bond
types, connectivity, chirality, and number of hydrogen atoms associated
with each atom were generated for all non-branched molecular fragments of
four to seven atoms in size.85 The number of occurrences of each fragment in
each molecule is recorded, producing an integer string as a descriptor of each
molecule. The fragment data sets are of much larger dimensionality than
the 2.5D descriptors. The original eight data sets are henceforth referred
to as 2.5D data sets, while the new data sets are referred to as the linear
fragment data sets.
To validate the performance of each classiﬁer, we have used the percent-
age of correctly classiﬁed molecules from 10-fold cross-validation as the mea-
sure for the model, averaged over 10 entire repeats of the cross-validation,
using diﬀerent random seeds. In cross-validation, the data set is split into
n folds; one fold is used for testing, the rest for training. This is repeated
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no. descriptors
data set compound type no. 2.5D fragments
compounds.
ACE angiotensin converting enzyme 114 56 1024
AchE acetyl-cholinesterase inhibitors 111 63 774
BZR benzodiazepine receptor 163 75 832
COX2 cyclooxygenase-2 inhibitors 322 74 660
DHFR dihydrofolate reductase inhibitors 397 70 952
GPB glycogen phosphorylase b 66 70 692
THER thermolysin inhibitors 76 64 575
THR thrombin inhibitors 88 66 527
Table 3.1: Summary of QSAR Data Sets
n times, so all the data have been used as test data once. The n errors
are averaged, giving the error rate for the data set. Ten is a commonly
used value for n.76 We stress that the reported cross-validated results are
for genuine predictions and distinct from the internal validation used by
some resampling techniques, which make use of the fact that approximately
one-third of the original training data is unused after bootstrap sampling.
Predictions on this unused data are known as out-of-bag (OOB) data. In
addition to the classiﬁcation accuracy, we assessed the robustness of the
models using the standard deviation of the accuracy across the 10 repeats
of the entire 10-fold cross-validation results, averaged for all data sets.
3.4 Results and discussion
Classifier Accuracy. We ﬁrst consider the results of the 2.5D data set.
The percentage of correctly classiﬁed molecules is given in the ﬁrst ﬁve
columns of Table 3.2. In general all classiﬁers perform reasonably, with
classiﬁcations between 67 and 90%. The strongest trends are clearly dataset-
dependent, with classiﬁcation being most successful on the ACE and DHFR
data sets, and least successful on the THER and THR data sets. As antic-
ipated, the decision tree classiﬁer is the least eﬀective of all the classiﬁers
studied, being the least accurate of the ﬁve methods studied in six of the
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data set tree
bagged
tree
boosted
tree
random
forest
SVM
tuned
forestb
tuned
SVMc
ACE 86.9 86.5 86.6 85.4 90.3 89.3 89.9
AchE 70.6 71.6 72.7 72.6 72.0 79.5 74.3
BZR 71.7 75.5 75.4 74.0 77.4 79.5 81.6
COX2 75.6 75.7 76.1 73.4 75.4 75.7 75.2
DHFR 78.8 83.2 83.4 83.1 79.6 84.9 82.2
GPB 70.6 74.5 76.2 74.1 73.9 76.7 75.3
THER 67.2 69.2 67.8 69.7 69.5 74.6 74.6
THR 66.5 69.1 68.0 69.1 67.2 72.5 69.0
Table 3.2: Percentage of Correctly Classiﬁed Molecules for Diﬀerent Clas-
siﬁers on 2.5D Descriptor Data Setsa
aValues in bold denote the highest accuracy for that data set. b100 trees.
cPolynomial kernel, exponent = 2, complexity constant = 0.05.
eight data sets. However, it still performs creditably, as the diﬀerence be-
tween the best and worst and classiﬁer is no more than 6% on any data set.
Additionally, it should be borne in mind that the average standard devia-
tion of the cross-validation accuracies was 2.5%, with the smaller data sets
(GPB, THER, and THR) showing larger standard deviations in the results
than the larger data sets. Contrary to our expectations, SVM was the best
classiﬁer on only two data sets. However, the Weka default is to use a linear
SVM; we assess the performance of a nonlinear SVM below.
The ensemble classiﬁers (bagging, boosting, and random forest) im-
proved classiﬁcation accuracy over the decision tree for all of the data sets
except ACE. Within the ensemble techniques, there was little diﬀerence in
performance. Boosting had a slight edge over bagging and random forest,
outperforming both on ﬁve data sets. Having established the default be-
haviour of the algorithms as implemented in Weka, an obvious avenue of
exploration for improving the performance of the ensemble classiﬁers is to
increase the number of trees in the ensembles. Additionally, random forests
have an extra parameter, the number of descriptors available to the tree-
building algorithm when creating branching rules, which we investigated
57
separately. First, we increased the number of trees in the aggregates from
10 to 200 in steps of 10. Similar results were observed for bagging, boost-
ing, and random forest. We concentrate on random forest in the following
discussion, because it improved the most upon adding more trees, but the
comments below apply equally to boosting and bagging. Accuracy increased
upon adding more trees, reaching a maximum for all data sets between 30
and 50 trees. Little improvement in accuracy was observed beyond this
point. The robustness of the accuracies was also improved with an increas-
ing number of trees, although the improvement is not monotonic, as can be
observed in Figure 3.1. Robustness is the average standard deviation of the
accuracy across all 10 repeats of the 10-fold cross-validation results.
Figure 3.1: Robustness with increasing number of trees (on 2.5D descrip-
tors). Legend: ACE (¨); AchE (¥); BZR (N); COX2 (×); DHFR (∗); GPB
(•); THER (¤); THR (♦)
Nonetheless, at 100 trees, the robustness of all trees is increased over
that observed for 10 trees, with all standard deviations below 2%. No
obvious improvement is observed upon increasing the number of trees to
200. Hence, we consider the 100-tree forest as “converged”. The accuracies
for random forest classiﬁers built with 100 trees are shown in Table 3.2, in
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the random forest column marked “tuned”. The improvement in accuracy
over the 10-tree forest ranges from 2 to 7%. To establish whether the
diﬀerence in performance was statistically signiﬁcant, a two-tailed paired
t-test81 was carried out on 10 versus 100 trees, using 100 repeats (10-fold
cross-validation repeated 100 times with diﬀerent random seeds). For all
data sets, the improvement in performance is statistically signiﬁcant at p =
0.001 for 100 trees. Second, we looked at the number of features available
during tree construction, a parameter available only for random forests.
By default, only log2M + 1 descriptors, selected randomly, are available
for selection to construct each branching rule in a tree, where M is the
total number of descriptors in the data set. For the 2.5D descriptors, this
corresponds to six or seven descriptors per branch. We therefore looked at
increasing the descriptor choice to 10, 20, 30, and 40 descriptors. To ensure
our results were not dependent on the choice of random seed, we repeated
the procedure 10 times, for two diﬀerent forest sizes with 10 and 30 trees.
The results showed that increasing the descriptor choice did not provide a
consistent improvement, and in most cases, the default value was optimal.
Therefore, we retained the default setting.
While increasing the number of trees in ensemble algorithms provides a
clear means for optimizing performance, a principled approach to improving
the SVM is more diﬃcult to achieve, simply because it has a much larger
number of parameters to modify. Our initial experiments suggested that
two parameters had the greatest eﬀect on SVM: the complexity constant
and the type of kernel (polynomial or RBF). Associated with both kernels
was a single parameter: the exponent for the polynomial kernel and the
γ value (RBF width) for the RBF kernel. We therefore chose an optimal
set of these parameters based on the mean accuracy across all eight data
sets. For the polynomial kernel, setting the exponent to 2, with the lower
complexity constant, produces the best predictions (see Table 3.3). Using
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Complexity Constant Polynomial exponent RBF γ
1 2 3 0.001 0.01 0.1
0.05 68.7 77.8 75.5 53.5 51.4 59.0
1 75.7 76.1 74.0 52.5 67.2 75.2
50 74.1 74.0 73.6 71.1 76.5 77.0
Table 3.3: Mean percentage of correctly classiﬁed molecules for diﬀerent
parameters of SVMs on 2.5D descriptor datasets. Values in bold denote the
highest accuracy for that kernel.
the RBF kernel, the SVM’s performance is more sensitive to the complexity
constant. With the default complexity constant, an increased γ value gives
improved results, which are similar to the default γ with a larger complexity
constant. Increasing the γ with the higher complexity constant improves
most datasets further, giving the best result with a RBF kernel.
Only the accuracies for the best SVM results are given in Table 3.2,
under the SVM column“tuned”. The results show that a nonlinear SVM
can improve performance for six out of eight data sets over the default linear
SVM implementation in Weka. However, the performance of the 100-tree
random forest is still superior to the tuned SVM for ﬁve of the eight data
sets.
Having established some useful parameters and observed a pattern of
behavior across the eight data sets with the 2.5D descriptors, we investigated
whether similar results could be obtained using the fragment descriptors.
Classiﬁcation accuracies are given in Table 3.4. The SVM performance,
after tuning the complexity constant and one kernel-speciﬁc parameter, is
shown in Table 3.5. Altering the complexity constant on the polynomial
kernel has little eﬀect on performance, no matter which exponent is used.
Using the RBF kernel with the default complexity constant and increasing
the γ has a positive eﬀect. The higher γ setting can give the best results.
Results are comparable to those of the 2.5D descriptors. The diﬀerence
between the most and least accurate classiﬁer was slightly increased, ranging
between 2 and 8%, depending on the data set. Again, the ACE and DHFR
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data set tree
bagged
tree
boosted
tree
random
forest
SVM
tuned
forestb
tuned
SVMc
ACE 80.4 82.0 81.0 80.5 78.9 80.0 82.2
AchE 64.1 68.0 68.8 70.5 69.4 70.5 77.1
BZR 74.0 75.0 69.8 67.3 74.0 68.7 75.8
COX2 71.1 71.5 71.0 68.1 72.6 68.7 71.1
DHFR 84.4 85.4 83.1 84.9 83.5 85.5 86.5
GPB 73.8 75.6 76.2 74.5 77.4 75.2 76.7
THER 72.2 75.8 75.5 75.4 75.3 76.7 73.4
THR 71.5 69.2 68.8 66.7 71.1 68.4 69.8
Table 3.4: Percentage of Correctly Classiﬁed Molecules for Diﬀerent Clas-
siﬁers on Linear Fragment Descriptor Data Setsa
aValues in bold denote the highest accuracy for that data set. b100 trees.
cRBF kernel, γ = 0.1, complexity constant = 1.
Complexity Constant Polynomial exponent RBF γ
1 2 3 0.001 0.01 0.1
0.05 74.5 73.4 73.1 51.8 53.8 59.5
1 75.3 73.3 73.1 62.0 72.8 76.6
50 73.3 73.3 73.1 75.9 74.7 73.6
Table 3.5: Mean percentage of correctly classiﬁed molecules for diﬀerent
parameters of SVMs on linear fragment descriptor datasets. Values in bold
denote the highest accuracy for that kernel.
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data sets are the easiest to classify. However, a clear diﬀerence emerges
when comparing performances based on the number of molecules in the
data set. For the “small” data sets (≤100 molecules), accuracies improve
upon moving to a higher dimensionality of descriptors. Conversely, for
the large data sets (≥100 molecules), the majority of classiﬁers record a
decrease in accuracy. As the larger data sets are described by a larger
pool of descriptors, this may suggest that the increase in the dimensionality
of the descriptor space outstrips the increase in information provided by
the larger data sets; that is, the “curse of dimensionality”143 is occurring.
The decision tree classiﬁer was not invariably the worst classiﬁer tested,
and for the THR data set, it was the best. However, for all other data
sets, at least one of the ensemble algorithms was able to improve upon the
decision tree performance. Bagging was the best at this, while boosting
and random forest could improve over the standard decision tree in four
and ﬁve data sets, respectively. As with the 2.5D descriptors, the SVM was
the best classiﬁer on two data sets. Increasing the number of trees to 100
in the random forest improved the accuracy for six out of eight data sets.
However, there was less improvement in robustness in going to 100 trees,
compared to the 2.5D descriptors, as shown in Figure 3.2.
A two-tailed t-test showed no signiﬁcant diﬀerence for p = 0.001 for
the AchE, COX2, and GPB data sets. It is conceivable that the larger
dimensionality of the fragment data set requires a larger number of trees in
the ensembles; however, increasing the number of trees to 1000 did not result
in any major increase in accuracy or robustness. Again, there was no clear
improvement in the performance of the random forest when the number
of descriptors available to the tree-building algorithm was increased. For
the fragment descriptors, a RBF SVM was found to be optimal and gave
the best performance of any algorithm on the fragment descriptors for four
data sets. However, boosting, bagging, and random forests gave comparable
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Figure 3.2: Robustness with increasing number of trees (on linear fragment
descriptors). Legend: ACE (¨); AchE (¥); BZR (N); COX2 (×); DHFR
(∗); GPB (•); THER (¤); THR (♦)).
accuracies on all of the data sets, except AchE and COX2, where one or
more of the algorithms struggled.
In order to put these observations on a more quantitative footing, we
carried out a multiple-comparison statistical analysis, using the Friedman
statistic, with a correction by Iman and Davenport, to detect the existence
of a statistically signiﬁcant diﬀerence between the classiﬁers. This test does
not, however, identify which classiﬁers are diﬀerent, only that a diﬀerence
exists. To identify signiﬁcantly diﬀerent classiﬁers, we perform a post-hoc
test using the Nemenyi test. Details of the procedure to carry out these tests
are given in the Chapter 2. For these tests, we pooled the results for both
sets of descriptors, giving N = 16 data sets. Both the default and tuned
versions of the SVM and random forest classiﬁers were considered separately,
making k = 7 classiﬁers. Carrying out the Friedman test with the Iman
and Davenport correction indicated that statistically signiﬁcant diﬀerences
between the classiﬁers existed at the p= 0.01 signiﬁcance level. We therefore
carried out the Nemenyi post-hoc analysis to determine which classiﬁers
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were signiﬁcantly diﬀerent from each other. It is a known weakness of the
Nemenyi test that it has a smaller power than the Friedman test. However,
it was still possible to detect statistically signiﬁcant diﬀerences between
classiﬁers at p = 0.05. Thus, we can deduce that the performance of the
tuned SVM (with the best average rank over all 16 datasets), and tuned
random forest are signiﬁcantly diﬀerent from the performance of a single
decision tree (with the lowest average rank over all datasets). However,
it is not possible to detect whether SVM is statistically diﬀerent from the
ensemble algorithms, or if, in turn, the ensemble algorithms are signiﬁcantly
diﬀerent from the use of a single decision tree.
Interpretation of Tree Models. Beyond assessing the predictive ca-
pabilities of the ensemble methods, we also sought to characterize the inter-
pretability of the resulting models. Decision trees are widely used for their
interpretability; therefore, an examination of the ensemble might provide
similar insights. There are two main issues to account for in an interpreta-
tion of an ensemble: the size and shape of each individual tree and dealing
with the large number of trees generated. Figure 3.3 shows two trees, one
generated by the J48 algorithm (a) and one that is part of a random forest
ensemble (b). For clarity, we have not displayed the value of the descriptor
threshold applied at each branch. The trees were used to predict activity
for the ACE data set using the 2.5D descriptors but have been chosen to
represent the typical structure observed across all eight data sets. It is ap-
parent from Figure 3.3 that decision trees generated by J48 are less “bushy”
and less balanced than those used in random forest. This is a consequence
of the pruning that takes place in the J48 algorithm, which is not applied
to the trees grown for use in random forest. Terminal leaf populations are
therefore on average smaller in trees in the random forest ensemble, and
this makes interpretation less reliable for these nodes. Note also that the
random tree contains the IC descriptor (a descriptor related to information
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theoretic concepts of entropy) twice. An analysis of the descriptors used in
the ensembles and the J48 trees shows a reasonable degree of overlap for
most data sets. One exception to this was with the ACE data set, where
J48 decision trees often contain a descriptor indicating the presence of a
nitrogen atom type; these were rarely chosen in the ensembles.
Figure 3.3: Decision trees classifying activity of the ACE data set generated
by (a) the J48 algorithm with pruning and (b) the random tree algorithm
without pruning. Descriptors deﬁnitions are in Table 3.6
We next consider the descriptor analysis of ensembles as a whole in more
detail. We focus here on the frequency with which descriptors are chosen
to appear in the trees. One obvious aid to interpretability would be if a
subset of descriptors was chosen with a frequency much higher than that of
others. To see whether this is the case, we recorded which descriptor was
selected for each branching rule in a 100-tree random forest, for all eight
data sets. We then plotted the number of descriptors as a percentage of the
total number used in the forest against the number of unique descriptors
selected. An example for the DHFR data set is shown in Figure 3.4.
Results for all the other data sets showed the same shape. The diagram
can be interpreted similarly to a receiver operating characteristic curve.
If only a few descriptors were selected by the tree-building algorithm, we
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Abbreviation Deﬁnition Reference
CHI-V-2 Valence-modiﬁed connectivity index, 2nd or-
der
144
Density Density (spatial descriptor)
IC Multigraph information content index
Jurs-DPSA-1 Diﬀerence in charged partial surface ar-
eas: partial positive solvent-accessible sur-
face area minus partial negative solvent- ac-
cessible surface area
145
Jurs-PNSA-3 Atomic charge weighted negative surface
area: sum of the product of solvent-accessible
surface area x partial charge for all negatively
charged atoms
145
Jurs-TPSA Total polar surface area: sum of solvent-
accessible surface areas of atoms with abso-
lute value of partial charges greater or equal
than 0.2
145
JX Balaban index 146
N dssC Number of times that each intrinsic state oc-
curs for a double/single/single bonded car-
bon cluster
147
N sssCH Number of times that each intrinsic state
occurs for a single/single/single bonded
methyne group
147
PMI-mag Principal moment of inertia 148
S aaCH Summed diﬀerences between all intrin-
sic state values for an aromatic/aromatic
bonded methyne group
147
S aasC Summed diﬀerences between all intrinsic
state value for an aromatic/aromatic-single
bonded carbon cluster
147
Shadow-XZfrac Fraction of area of molecular shadow in the
XZ plane over area of enclosing rectangle
149
Table 3.6: Descriptor deﬁnitions from the decision trees in Figure 3.3
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Figure 3.4: Percentage of model explained by unique descriptors for the
DHFR data set.
would expect to see an initially steep vertical line at x = 0, indicating that
most trees consisted of a few descriptors. This pattern is not observed to a
large extent, although it can be seen that 50% of the branching points in
the DHFR ensemble consist of 20 descriptors, which represents only 25% of
the total number of descriptors chosen. Therefore, it seems that no “super
descriptors” emerge from the random forest ensemble. This is perhaps to be
expected, given that only approximately seven descriptors, chosen randomly
from all descriptors, are available for selection at any given branch point
during tree construction. A related issue is whether the same descriptors
are chosen most frequently in ensembles of diﬀerent sizes. We considered
the top 10 most frequently chosen descriptors for this purpose and examined
the eﬀect of increasing the number of trees in the forest from 100 to 1000 in
steps of 100 trees. Larger data sets show greater consistency: the same top
10 descriptors are present in all forests for the DHFR, the largest data set.
As the data sets grow smaller, there is less overlap between the en-
sembles, with only seven descriptors consistently found in all forests for
ACE, AchE, and BZR. For the small data sets (GPB, THER, and THR),
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at most three descriptors are in common across all forests. Despite this
variability for some data sets, some commonly occurring descriptors can
be identiﬁed. Atom type descriptors are commonly found, which describe
hybridization and bonding information associated with an atomic centre;
these are conceptually similar to the fragment descriptors. Additionally,
some frequently occurring whole-molecule descriptors could be identiﬁed
for some data sets. For the ACE data set, we identiﬁed IC and JX as falling
into this category; they correspond to information entropy and the Balaban
index,146 respectively. The latter topological descriptor accounts for both
cycles and conjugation in a structure, and active compounds in this data
set are well-characterized by the presence of aromatic rings. Conversely, for
the COX2 data set, electronic and partial surface area descriptors (Apol
and Jurs-RPCG) are frequently selected. This would suggest that the over-
all electronegativity of the compounds is important for activity. For the
DHFR data set, topological and partial surface area descriptors appeared
in all forests (Kappa-3, Jurs-FPSA-3, and Jurs-FNSA-3). This shape and
surface information can help distinguish between inactive compounds which
may have longer, positively charged chains, for example, nitrogen cations,
which are less favourable than short, negatively charged chains.
Using the tools developed in Chapter 4 we can extend our original inter-
pretation. Based on a 100 tree forest built on the DHFR data set. Kappa-3,
Jurs-FPSA-3, and Jurs-FNSA-3 were identiﬁed as descriptors which ap-
peared frequently when altering the size of the forest. For this forest the
top descriptors are S aaN, S sNH2, S aaCH, Kappa-3, S aaaC, S ssCH2,
Jurs-FNSA-3, AlogP98, S aasC and Jurs-FPSA-3. Those previously high-
lighted are identiﬁed again. These top ten descriptors account for 29% of
the branches in the overall forest. A total of 69 descriptors are used in the
forest, the data set contains 70. Analysing the majority vote reveals that
each tree on average incorrectly classiﬁes 26 compounds. All the trees build
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capable models, no single tree stands as out as a poor predictor. Looking
at the performance of individual compounds 46 are correctly predicted by
all trees. 72 out of 100 votes is the lowest majority across the forest. 14
compounds received 80 or fewer correct votes.
3.5 Conclusions
Over the eight data sets, the support vector machine was the best of the
classiﬁers studied, whether using the 2.5D descriptors or the fragments. We
conﬁrmed this superiority over a single decision tree through a multiple
comparison statistical test. However, statistical signiﬁcance should not be
confused with practical signiﬁcance, and the performance of boosting, bag-
ging, and random forest was in most cases comparable with that of SVM,
and in some cases superior. Furthermore, achieving the optimal perfor-
mance for SVM can be a formidable task, because of the large number of
parameters associated with it. We did not succeed in ﬁnding a set of param-
eters that was universally applicable. For example, a quadratic polynomial
kernel was optimal for the 2.5D descriptors, while a RBF kernel was best
for the fragment descriptors. Conversely, boosting, bagging, and random
forest have fewer parameters, while performing competitively with the best
SVM results. All of the ensemble algorithms beneﬁted from the use of an
increasing number of trees - these had a generally positive eﬀect on both
classiﬁcation accuracy and robustness. We were able to identify 100 trees
as being an optimal setting for most cases, and we recommend that users of
the Weka machine-learning workbench use this value for cheminformatics
applications, rather than the smaller number available as a default. Other
packages such as R have a higher default value of 500 trees. However, this
has an impact on training speed. For the larger datasets and high dimen-
sionality descriptors training one forest could take up to a week. We did
run some larger forests of 1000 trees but did not see statistically signiﬁcant
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improvement in accuracy. When considering interpretation a larger forest
only increases the size of the model. This may be not desirable and could
make interpretation more complex. To generate large forests in a reason-
able time a parallel implementation of random forest were be required. The
algorithm is ideally suited to being run in parallel. However, our recom-
mendation would be to have a forest which is larger enough, for example
100 trees not 10. Adding thousands of more trees may not add any value,
just computational cost. In general, all the algorithms we studied were
marginally less eﬀective for the more numerous linear fragment descriptors.
While the dimensionality of these descriptors was large, even by current
standards (1000 descriptors per data set), data sets are likely to become
larger in the future, rather than smaller. Although ensemble algorithms
like random forest were designed with high dimensional data sets in mind,
cheminformatics data sets tend to be at least an order of magnitude larger,
in terms of the ratio of descriptors to observations, than those commonly
found in machine learning. An additional advantage of decision-tree-based
methodologies is their potential to provide interpretable models. We have
found that there are challenges associated with extending this interpreta-
tion to ensembles. In particular, trees in the ensembles are “bushier” than
standard decision trees. A descriptor-level frequency analysis can provide
some insight, but for the data sets studied here, there was a wide distribu-
tion of descriptors in the ensemble, so attempting to select a small subset of
descriptors from the ensemble is somewhat subjective. Therefore, choosing
a decision-tree-based learning algorithm over the SVM may be less advan-
tageous than hoped. Despite the success of random forest and SVM on our
data sets, a single decision tree was surprisingly competitive, and its inter-
pretability is not in doubt. Clearly, therefore, along with more sophisticated
ensemble-building algorithms, there is substantial scope for concomitantly
advanced procedures for extracting information from decision tree ensem-
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bles, and this will be the focus of Chapter 4.
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Chapter 4
Random forest: an
interpretable classifier
4.1 Introduction
Random forest is a capable and increasingly popular machine learning tech-
nique. Part of its appeal is the availability of interpretation, typically using
a descriptor frequency count. We have previously shown that a random
forest performs well compared to a SVM, widely considered the current
benchmark. In addition, extensive parameter optimisation is not necessary
and even if undertaken is a far quicker task, as fewer parameters are avail-
able. The insight that a model can provide is possibly of more importance
than gaining an extra 5% in predictive accuracy. Insight from the model can
be relayed to medicinal chemists, which can be used in lead optimisation
strategies. Any information that explains the activity of a compound series
is invaluable within drug discovery.
Within the QSAR community there are doubts over the usefulness of
QSAR. Some question if QSAR contributes positively to drug discovery or
reports chance correlations, not novel insight. The ﬁeld must not stagnate
by focusing purely on predictive performance. Recent work has highlighted
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the concern with QSAR.27,150–152
Speciﬁc tools are required to interpret a random forest. While someone
can interpret a single decision tree, it would be a painstaking task to review
100 larger trees from a forest. The construction of random trees in Weka
leads to larger unpruned trees, making even a single tree unwieldy. In
addition, the relationships between the trees could be of importance. We
have explored various avenues to extract information from the forest.
This chapter will ﬁrst validate the suitability of random forests on larger
and more complex data sets. Here, complexity is in terms of a three class
problem, where the balance of classes is skewed unfavourably. Most ma-
chine learning techniques struggle with skewed data. Therefore commonly
used techniques to compensate skewed data are applied. Second the in-
terpretability of the forest will be probed. Our in-house software, FBI,
will demonstrate various features. Functionality of FBI includes descrip-
tor frequency counts, tree depiction, transforming trees into SMILES and
SMARTS notation, details on the majority vote and individual molecule
performance.
4.2 Methods
The performance of random forests has already been demonstrated in Chap-
ter 3. However, these data sets are smaller than the data sets typically used
in pharma. We demonstrate the application of random forests on a larger
and more challenging data set from GlaxoSmithKline. This data is propri-
etary, but is used here to demonstrate the predictive performance of the
forest. Unlike the Sutherland and Weaver data sets, this has three classiﬁ-
cations, and is thus a harder task. The distribution of the classes is uneven.
This also poses a challenge to a data mining technique. Due to the greater
availability of data at GlaxoSmithKline, three data sub-sets are possible.
A large training set, a small hold or validation set to perform parameter
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Data set size
Train Hold Test
Instances 7999 2217 4000
Class distribution
Low Medium High
Percentage 77 14 9
Table 4.1: Composition of GSK data set and distribution of classes
tuning and a medium-sized test set are used. This has the advantage of the
data being completely independent. The model never sees the same data
twice, as is the case with cross-validation. Each stage of the model has new,
unseen, data. The data set itself comprises in-house data with 122 in silico
descriptors. The descriptors represent common physical chemistry proper-
ties and e-states153, also generated in-house. The electrotopological state,
or e-state descriptors generate a value for each atom of a molecule encod-
ing the topological environment and electronic interactions with all other
atoms. E-state indices can be formed for common functional groups. One
such index denoted as “SssCH2”, represents CH2 groups. “Sss” represent
three single bonds.
The Table 4.1 summarises the data set composition. As one would ex-
pect, less high activity data is available than low or medium. It is the high
activity compounds that are of most interest and the successful prediction
of other high activity compounds. In highly skewed data sets data mining
techniques have a tendency to classify everything as the majority class, in
this case low activity. Statistically this would look like good performance,
e.g. 90% is a excellent score. This underlines the importance of not relying
on a single statistic. On closer inspection, this model is ﬂawed for high ac-
tivity prediction, as it successfully identiﬁed all the low activity compounds
and labelled most other compounds low activity as well. Close attention to
the confusion matrix is required for data sets like this. Skewed data sets
are not a new problem and there are techniques to adjust the model. We
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use cost sensitive classiﬁcation20 and over sampling.154
In this chapter, our data are quite diﬀerent to those used in Chapter
3. Not only are they larger and thus allow train, hold and test data sets,
but possess three classiﬁcation classes. Having more data is advantageous
as we can perform both the training and testing of the model with unseen
data. Multiple classes are not a problem as long as the method can handle
them. Modern implementation of these methods are suitable for multiple
classes. SVM as implemented in Weka cannot handle multiple classes. This
is overcome by performing multiple pairwise calculations of the classes to
obtain a prediction for each class. The issue comes with the distribution of
the classes. If they are unbalanced the model may be biased to the major-
ity class, and this may not be the class of interest. Therefore, in addition
to the normal procedure of model building and statistics, there are other
techniques one would use in this situation. In cost sensitive classiﬁcation,
a cost matrix is used to penalise the learning algorithm when a certain
classiﬁcation is made. Weka supports this across most classiﬁers, including
random forest. The cost matrix used is determined by trial and error, but
a default matrix as in Table 4.2 is a reasonable starting point. Depend-
ing on the distribution of the classes one will need to adjust the costs to
avoid a misclassiﬁcation. The cost matrix can be used with any number of
classes, although ﬁne tuning will become more complicated as the number
of classes increases. Ultimately one will ﬁnd that one goal must be picked,
e.g. optimise one class.
Another approach to unbalanced data is under and over sampling. These
techniques relate to altering the data set composition. The reason the model
is biased to the majority class is the high frequency of instances. Under
and over sampling oﬀer two approaches to remove the split and return the
data set to equal distributions of the classes. Therefore, when the data is
modelled, all classes have equal representation. Only the training data sets
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Actual/Predicted A B C
A 0 1 1
B 1 0 1
C 1 1 0
Table 4.2: Default cost matrix. No penalty for predictions on the diagonal,
which are correct.
are modiﬁed. Subsequent data sets are not altered. Under sampling reduces
the size of the data set so that all classes have the same number of instances
as the minority class. This has the disadvantage that not all available data
is used in the model. Over sampling is the opposite and increases the size
of the dataset. Minority classes are duplicated to match the size of the
majority class. The model will learn the same instances more than once
and this will bias the overall model to recognise that class. To analyse
the model, the confusion matrix is important to check for false negatives,
typically in the minority classes, see Chapter 2. For statistics the Matthews
correlation coeﬃcient is not suﬃcient as this not a binary class problem.
Instead one can use the Kappa statistic, as described in Chapter 2.
FBI was developed in this thesis to allow interpretation of random forest
models. It is a Java-based GUI suitable for running on any major operating
system. It does not have a batch or command-line version, as interpreting
models is far less computationally demanding than generating them. To
avoid rewriting core machine learning code Weka is included as its existing
framework can be taken advantage of. This is possible thanks to its API,
documentation and open source (Apache155) license. FBI was not devel-
oped for Weka’s random forest implementation. It can read saved models
from other popular applications. However, with the presence of Weka its
implementation is available to allow anyone to generate a forest.
FBI’s development followed the programmatic approach as described in
the Chapter 1. All source code is held in our group subversion repository.
JUnit tests were written and run whenever the code is compiled. For deploy-
76
ment IzPack is used to enable a simple wizard-based installation. An Ant
build script (the Java equivalent of a Makeﬁle) can compile, test and package
the code into the IzPack installer. This script is what CruiseControl uses to
independently build everything after a commit to the repository. Program
documentation is available as HTML webpages or in PDF format. Docu-
mentation is written in reStructuredText, a lightweight markup language.
A Python package, Sphinx156, will convert the source into the target format
via a Makeﬁle. The Ant build script also handles the documentation com-
pilation. The installer for FBI along with documentation is available on our
group website: http://comp.chem.nottingham.ac.uk/download/fbi. Iz-
Pack44 provides native installers for users of Windows and Mac OS X, so
users will not notice they are using Java. Using the installer can also, op-
tionally, add Desktop and Start Menu shortcuts for the user. An installer
is only as good as the uninstaller it provides. All IzPack installations are
simple to completely remove. The Java runtime environment is the only
prerequisite, which is commonly installed otherwise, it is readily and freely
available from http://www.java.com. For the same reason that Weka is
included with FBI so are Marvin and JFreeChart. Marvin provides the de-
piction of SMILES5 and SMARTS,9 while JFreeChart provides plots from
some of the analyses. FBI was not written to provide its own API, but this
could be introduced retrospectively.
Arguably the ﬁrst task to perform when analysing a forest is to view
the trees produced. Weka displays a text version of the trees it generates,
that while technically accurate are not visually useful. Subsequently Weka
introduced a tree visualiser that allows basic viewing and manipulation of a
tree. FBI contains custom code, most of which has been contributed back to
Weka that allows trees from a forest to be extracted and viewable in the tree
visualiser. The tree component in the random forest was not compatible
with the tree visualiser. In addition, instance data is also available by
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clicking the various nodes when using the tree visualiser.
The concept of a tree is common and highly studied in Computer Science.
Graph theory is one implementation of a tree structure, a selection of nodes
and edges (or leaves and branches). Cheminformatics also uses graph theory
to encode chemical structures as atoms (nodes) and bonds (edges). Given we
are interested in chemical insight to our forest it was opportune to convert
our tree structures into chemical entities (although they will not contain
any actual chemical meaning). With the forest in a popular chemical format
there are many pre-existing tools with which they can now be processed.
SMILES5, simpliﬁed molecular input line entry speciﬁcation, is a popular
and de facto 2D chemical format. SMILES are simple and human-readable
where letters represent atoms and bonds are implicit. Benzene is encoded
as c1ccccc1, where the ring opening and closing is signiﬁed by the same
number. Lower case letters encode for aromatic atoms, while upper case
represents aliphatic atoms. Therefore, cyclohexane would be C1CCCCC1.
Compounds with branches are handled by parentheses, for example, acetic
acid, CC(=O)O. Bonds are denoted by equals or hash symbols for double
and triple bonds respectively. There are only a handful of simple rules to
enable one to interpret SMILES, which is part of the reason they are so
popular. A valid SMILES representation can start from any point of a
molecule. Therefore, they are many potentially valid and unique SMILES
for the same compound. Canonicalisation is a process to produce a unique
SMILES representation. This is particularly useful in databases or when
comparing SMILES against each other.
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Actual/Predicted L M H
L 3026 13 23
M 516 14 40
H 272 17 79
Table 4.3: Confusion matrix for the default random forest reporting the test
set results.
Actual/Predicted A B C
A 0 2 5
B 20 0 5
C 20 10 0
Table 4.4: Cost matrix for the cost sensitive random forest. No penalty for
the (correct) predictions on the diagonal.
4.3 Results and discussion
4.3.1 Larger and skewed data
Using the training data to build our forest of 100 trees, we report the results
of the training data (4000 instances) and apply techniques to take account of
the skewed class distribution. Using just the random forest, we obtain 78%
correctly classiﬁed compounds and Kappa statistic of 0.17. Table 4.3 shows
the confusion matrix. It is clear that the bulk of compounds have been
predicted as low activity. We are more interested in the medium and high
activity classes, of which only 2.5% and 21.5%, respectively, were correctly
predicted. The overall correctly classiﬁed percentage is misleading, but the
low Kappa statistic highlights the incorrect classiﬁcations. The low activity
class is nearly perfectly predicted at 98.8%.
By applying a cost matrix, we can inﬂuence the forest not to classify
Actual/Predicted L M H
L 2758 205 99
M 363 114 93
H 150 81 137
Table 4.5: Confusion matrix for the cost sensitive random forest reporting
the test set results.
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Actual/Predicted L M H
L 2741 214 107
M 356 121 93
H 144 86 138
Table 4.6: Confusion matrix for the oversampled random forest reporting
the test set results.
medium and high activity instances as low activity. Several cost matrices
were used. Table 4.4 is what produces the confusion matrix in Table 4.5.
The correctly classiﬁed rate was 75% and the Kappa statistic 0.30. The
use of a cost matrix improves the overall correct classiﬁcation, as reﬂected
by a higher Kappa statistic. The total number of correct classiﬁcations is
lower, but the improvement to the medium and high activity compounds
is obvious. 20% and 37.2% of the medium and high activity compounds,
respectively, are correctly classiﬁed. This represents a two-fold improve-
ment for the high activity compounds and eight-fold for medium activity
compounds. The medium activity compounds are harder to predict, as they
have boundaries with both low and high activity compounds. Further at-
tempts to improve the cost matrix led to either the medium or the high
correct classiﬁcation falling at the expense of the other. The low activity
compounds are not as well predicted in this model. However, the correct
percentage is still very high and our focus is the more active compounds.
We applied over sampling to the training data set, which increased its
size. The test set remains the same. Using just over sampling achieves
similar results to the cost sensitive classiﬁcation. The fraction of correctly
classiﬁed compounds was 75% and the Kappa statistic was 0.30. The con-
fusion matrix is very similar, as seen in Table 4.6 and demonstrates the
eﬀectiveness of this technique for handling the skewed classes. The percent-
age correct by class is essentially the same. However, we would ideally want
the percentages to increase nearer 50% for all classes.
The techniques complement each other, and combining them improves
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Actual/Predicted A B C
A 0 10 5
B 20 0 5
C 20 15 0
Table 4.7: Cost matrix for the cost sensitive and oversampled random forest.
No penalty for (correct) predictions on the diagonal.
Actual/Predicted L M H
L 2314 600 148
M 215 238 117
H 80 132 156
Table 4.8: Confusion matrix for the cost sensitive and oversampled random
forest reporting the test set results.
the results. A diﬀerent cost matrix is used, as the composition of the train-
ing data set has now changed, shown in Table 4.7. The overall correctly
classiﬁed rate is 68%, while Kappa remains at 0.3. The confusion matrix
is shown in Table 4.8. Clearly, the total number of correct classiﬁcations
is lower than previously. However, that is due to the majority class only
being 75% correctly classiﬁed. The classes of interest have both risen to
over 40%, especially the middle class which often suﬀers at the expense of
the terminal classes. Random forest continues to prove its competence at
classiﬁcation of pharmaceutical data of varying type. The use of additional
machine learning techniques enables it to perform well with skewed data
sets.
4.3.2 Interpretation
When it comes to interpretating a forest, it is clear that visual inspection
alone is insuﬃcient. In fact, by default Weka does not display the trees
from the forest. This highlights the diﬀerent priorities between the machine
learning and cheminformatics communities. Even with the trees available,
they are far too large and unwieldy to be of any use, especially when pre-
sented as text. A tool was needed to assist with forest interpretation and
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handling the model. A Java application called FBI, Forest Based Interpre-
tation, was written to house all the required tools to create and interpret
models. Java was chosen, due to its platform independence. This became
especially useful as FBI was developed on a Mac, yet deployed on Windows
and Linux. FBI contains a copy of Weka with some slightly modiﬁed ﬁles to
enable one to obtain the trees produced by the forest. All further analysis
was performed outside Weka, to enable FBI to run newer versions of Weka.
When starting with FBI one can either generate a new random forest
or load a previously saved model. Once the forest is built, all analysis op-
tions become available. Previously, descriptor importance was ascertained
by counting the frequency of a descriptor in the trees as each split undergoes
attribute selection, even though the pool of available descriptors is only a
random subset. For the following examples, the ACE data set from Suther-
land and Weaver88 was used to create a 10 tree forest. Figure 4.1 depicts
the summary of descriptors across the forest. Graphs are produced in FBI
using the open source library JFreeChart157.
It is clear there are no super-descriptors, as Chapter 3 details. However,
it is reasonable to assume that the more commonly picked descriptors are
better at classifying this data set. FBI can drill further down to graph by
each tree in the forest. Tree 10 is shown in Figure 4.2. This is a small data
set and hence there is a lower overall number of descriptors. FBI provides
the numbers behind the graph as well, for the user to save and use elsewhere.
As well as the most common descriptors being of potential interest, the
descriptors at the top of each tree correctly classify a larger number of
instances. Therefore, they are also of interest. FBI can summarise the top
descriptors to a given depth.
One can view the trees in multiple formats. Firstly, Weka includes a
tree visualiser. This has been modiﬁed to enable easy viewing of multiple
trees, as shown in Figure 4.3. Secondly, we can produce SMILES5 and
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Figure 4.1: Summary of descriptor frequency across a forest using the ACE
data set
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SMARTS9 trees. Our motivation for converting the trees into a chemical
format is to allow ease of manipulation and enabled the use of existing
tools. The depictions from the chemical trees are instantly more familiar
to chemists and more meaningful than the visualisation that Weka pro-
vides. The SMILES trees are encoded using boron for the branches and
carbon for the leaves. In order to satisfy valency oxygen is used as the
root node. The SMARTS tree gives each descriptor in the tree a unique
number. This is encoded as the atomic number. Using SMARTS al-
lows an extra dimension of information to be encoded, namely identifying
the descriptor. Just like the SMILES tree the topology is also encoded.
Identifying the descriptor is useful for further analysis. The root node is
represented with the wildcard (*) atom. All information encoded in the
SMILES and SMARTS trees hold no chemical meaning; atom types were
picked for convenience. The information encoded in the trees is diﬀerent.
The SMILES tree details the topology of the tree, but tells one nothing
about the descriptors. The SMARTS tree additionally encodes the de-
scriptor detail with diﬀerent descriptors represented as ascending atomic
numbers. Samples of both are seen in Figures 4.4 and 4.5. Due to the tree
structure, which is not typically found in compounds, the actual SMILES
and SMARTS representations are parenthesis heavy and not particularly
readable. The original SMILES representation is O(B(B(C)B(C)(C))B(C)-
B(C)B(C)(C))B(B(C)(C))B(C)B(C)B(C)B(C)(C), which is canonicalised to
B(B(B(B(C)C)OB(B(B(B(C)C)C)C)B(B(C)C)C)C)(B(B(C)C)C)C. The SMARTS
is *(-[#1](-[#8](-[#9])-[#9](-[#10])(-[#10]))-[#8](-[#11])-[#11](-[#12])-[#12](-
[#13])(-[#13]))-[#1](-[#2](-[#3])(-[#3]))-[#2](-[#4])-[#4](-[#5])-[#5](-[#6])-
[#6](-[#7])(-[#7]). These trees have no chemical meaning but useful infor-
mation about the subgraphs is encoded in a format for which various tools
are readily available. For example, subgraph fragments can be searched
across all the whole forest to see if the same path repeats, which would
84
indicate this particular path encodes some importance of the selected de-
scriptors.
Figure 4.2: Summary of descriptor frequency across tree 10 using the ACE
data set
As FBI contains Weka, which has a fully ﬂedged API, one can take
advantage of this. For example, we can produce a scoring matrix based on
trees or compounds. They contain binary values for whether or not that
tree or compound was successfully classiﬁed. Weka also contains clustering
algorithms and a clusterer visualiser. Using the existing tools in Weka, we
can cluster our scoring matrix. It identiﬁes three clusters from this matrix.
Using the GUI interface the user is able to identify the instance number of
the cluster members.
The overall classiﬁcation is given by the majority vote of the trees. We
can now produce these numbers and plot them, as in Figure 4.6. No single
tree has a disastrous performance. This data set is fairly straightforward to
classify. Likewise, we can plot the performance of each molecule. A so called
molecule performance graph highlights which molecules posed the biggest
challenge to classiﬁcation. This is shown in Figure 4.7. Most molecules
are unanimously correctly predicted. However, there is a handful that are
misclassiﬁed by a few trees. These molecules are of interest to see why
some trees could not successfully classify them. In order to assist with
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Figure 4.3: Weka tree visualiser with added navigation panel to view trees
in a forest
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Figure 4.4: A tree encoded as SMILES. Oxygen (O) is the root node. This
representation has no chemical meaning.
Figure 4.5: A tree encoded as SMARTS. The wildcard atom type (A) is the
root node. This representation has no chemical meaning.
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ﬁnding misclassiﬁed compounds FBI can produce a list a molecules that
are incorrectly classiﬁed by x% of trees.
Figure 4.6: Summary of the majority vote for a forest built using the ACE
data set
4.4 Conclusions
Random forest is a powerful technique. It is competitive with other clas-
siﬁers on a variety of data sets, both small and large. While in theory it
is an interpretable method, it is clear that as an ensemble this is no longer
straightforward. The tools in FBI assist one in exploring the contents of
the forest. Simple statistics are the ﬁrst step to understanding the composi-
tion of the forest and individual trees. With the trees available in multiple
formats, text, SMILES, SMARTS and the tree visualiser, further analysis
is possible. The scoring matrix allow us to assess the performance of indi-
vidual trees and compounds. The overall classiﬁcation is the outcome of a
majority vote. We can examine the details of the vote and highlight the
border-line classiﬁcations. All the features within FBI add extra value and
insight to our model and the data that created it. The use of interpretable
descriptors enhances the beneﬁt of highlighting descriptor importance.
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Figure 4.7: Molecule performance for a forest built using the ACE data set
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The methods in FBI are by no means exhaustive, There are many av-
enues to explore further. However, it is a step forward from simple counts
and is a foundation for further research. Access to the trees in multiple
formats, particularly chemical, is perhaps the most important feature, as
this allows analysis in other applications. We have shown how a forest does
indeed contain useful insight into the model. The challenge is getting it to
a readily understandable form. FBI allows the user to gain a greater under-
standing of the model. Black box methods oﬀer no beneﬁt post prediction,
whereas model interpretation is invaluable in downstream analysis.
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Chapter 5
TMACC: interpretable
descriptors
5.1 Introduction
The descriptors used within a QSARmodel are arguably the most important
component. One can only assess and interpret a model based on the inputs
- the chosen descriptors. While thousands are available through software
packages and web services, how does one pick the best descriptors? It
was originally thought the more the better. However, more descriptors
increase the model generation time. Also extra descriptors add noise to
the model and increase chance correlations, both of which detract from the
aim of ﬁnding a chemical relationship. The increase in descriptor space
is not proportional to information gain. This is known as the curse of
dimensionality.143 Therefore, a reasonable number of descriptors should be
selected for a model. For interpretation, whole molecule descriptors are
not as useful. For example, Lipinski-like rules46 are useful ﬁlters, but not
suitable for structure-based drug design. This is because the rules classify
compounds on the likelihood of absorption. For compounds highlighted
as poor for absorption they do not suggest which part of the molecule is
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responsible. Descriptors that connect speciﬁc regions of the molecule with
an impact of a property are better suited for structure-based drug design.
Fragment-based descriptors are an example, as they represent a distinct
chemical entity.
The TMACC descriptors (See Chapter 2) were developed in this research
group.85 They are highly predictive topological maximum cross correlation
descriptors for use in QSAR. They are based on the autocorrelation method
and encode several chemical properties. Their generation does not require
3D structures or alignments. The original work demonstrates qualitative
agreement with more time consuming 3D and 4D QSAR methods. Here, we
focus on their interpretive ability by developing tools to test their interpre-
tative power. Used in conjunction with PLS, we explore the interpretation
of an angiotensin converting enzyme (ACE) dataset88 and performance in
the Journal of Chemical Information and Modeling (JCIM) solubility chal-
lenge.28
Activity, lipophilicity and solubility are important properties in pharma-
ceutical compounds and, thus, common targets for SAR studies. Activity
can be measured as IC50 or pKi. IC50 is the half maximal inhibitory con-
centration. This value represents how much drug is required to inhibit the
biological function of interest by half. Ki is the inhibition constant. This
is the equilibrium constant that measures the reaction of the ligand and
protein dissociation. pKi is equal to − log10 Ki. The octanol-water parti-
tion coeﬃcient, logP, is acknowledged to be relatively straightforward to
predict compared to other properties, such as solubility.158 The availability
of experimental data is crucial in predicting properties. Solubility poses a
challenge as producing reliable results is not as simple as other properties
using either experimental or computational methods. This, in part, could
explain why logP is easier to predict than solubility. Models built are sen-
sitive to the error of the data. Greater error yields less reliable predictions.
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This is common for solubility.
Solubility is the ability of a substance (known as a solute) to dissolve
in a solvent. Solubility is a dynamic equilibrium, which is maintained by
a constant rate when no more solute can be added to the solvent as it is
fully saturated. Due to the equilibrium nature of solubility it is pressure
and temperature dependent. In order for substances to dissolve a suitable
amount of energy is required to break the hydrogen bonds, otherwise they
will be insoluble, for example water and oil. If energetically favourable the
solute will form new hydrogen bonds with the solvent. Drugs need to be wa-
ter soluble in order to be orally bioavailable, which is the preferred method
of administration. Poor solubility can lead to late-stage failure, which is
costly. High-throughput technologies have led to increased lipophilicity and
molecular weight of screened compounds, which in turn reduces solubility.159
5.2 Methods
The ACE dataset from Sutherland and Weaver88 is used retrospectively to
validate the TMACC interpretation. The JCIM solubility challenge data set
was also used. Both are regression based tasks. The method follows that
outlined in Chapter 2. The goal of the solubility challenge was predictive
accuracy. Therefore, some modiﬁcations were implemented to improve this.
Two alterations to standard TMACC generation were explored. First, given
solubility is the goal and TMACC includes an explicit solubility term, we
altered the standard 28 atomic property pairs. We investigated only using
pairs with either one or both components being solubility, comparing to the
standard TMACC. As detailed in Chapter 2 TMACC descriptors are com-
posed of molecular property pairs based on electrostatics, molar refractivity,
logP and logS. Given the nature of this study we have explored using only
bias pairs to improve our solubility predictions. Second, we reduced the
cutoﬀ for the topological distance; by default it is the maximum possible.
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Both of these alterations enhanced performance.
TMACC interpretation is made possible by using NCW, Nottingham
Cheminformatics Workbench. Melville was responsible for the original TMACC
descriptor code, written in Java. NCW extends this by adding a GUI to
descriptor generation. The original code only generates descriptors. One
would then have to build a model and analyse the interpretation by hand.
Descriptor interpretation is not practical to be done manually. NCW, there-
fore, was written as part of this thesis work to automate it. Using NCW
one can generate descriptors, build a model and analyse the interpretation
in a graphical output, using Marvin.96 NCW is the now the default location
for all in-house cheminformatics code. This includes 3D QSAR and similar-
ity metrics12. A public version is available for download from our website
http://comp.chem.nottingham.ac.uk/download/ncw. NCW works on all
major operating systems and removes the need for extensive command-line
usage. A GUI installer makes installation simple while documentation is
available. In adherence with the open source Apache license,155 full source
is available, allowing others to extend and develop further if desired. The
GUI installer and documentation is provided using the open source projects
IzPack44 and Sphinx156. This work would not have progressed as far with-
out computational tools to enable analysis of the complete datasets, not
just a few molecules.
With solubility being such a challenging property various methods have
tried to predict it in silico. Four classes of descriptor are frequently used:
melting point and logP, atom or group contributions, physicochemical and
quantum chemical descriptors, and topological indices.158 The TMACC de-
scriptors are atomic physicochemical based. Unfortunately the techniques
employed by the 99 entrants of the solubility challenge were not disclosed,
this would be very interesting to see. Palmer et al have used random forests
to predict aqueous solubility.160 They used random forest, PLS, SVM and
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artiﬁcial neural networks for model generation using a variety of descriptors
from the Molecule Operating Environment (MOE). A comparison of the
models concluded that random forest was the most accurate. The random
forest implementation in Weka is limited to categorical data only. Therefore,
we did not used random forest in this exercise. Quantum chemical descrip-
tors have been used as well as the high level of theory accessible could aid
reliable prediction.161 However, the required level of theory is excessively
expensive. In this work the authors combined a lower level of theory with
informatics in order to enable a reasonable compute time. Both of these
studies have used diﬀerent approaches to how the TMACC operates. They
all have produced reasonable predictions for solubility.
Solubility training data: From the 101 molecules comprising the training
data, we removed the following: aspirin, chloroprothixene, 5-ﬂuorouracil,
levoﬂoxacin, L-proline, orbiﬂoxacin, Pen G, pthalic acid, procainamide,
sulindac, trichlormethiazide and chlorzaxazone. They were removed as they
either had no intrinsic solubility value or were polymorphs. This left 89
training compounds and 32 in the test set. All structures are available in
Appendix A. We converted the intrinsic solubility into log units. The pre-
dicted values are converted back to intrinsic solubility for the purposes of
assessment.
Solubility test data: After the results were published162, it was evi-
dent that several compounds would pose a challenge for our method. 2-
chloromandelic acid, 1R-2S-ephedrine, marboﬂoxacin and 1R-2R-pseudoephedrine
have no intrinsic solubility. Diﬂunisal and trazodone are polymorphs. Al-
though we made predictions, our method is not capable of predicting these
types of compounds.
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5.3 Results and discussion
5.3.1 Angiotensin converting enzyme
This work was carried out by Benson Spowage, an undergraduate project
student under my supervision, and it was only made possible by the avail-
ability of the NCW software.163 Figures 5.1, 5.3 and 5.4 were drawn by
Benson Spowage.
Angiotensin converting enzyme, ACE, is part of the body’s system to
regular the volume of blood and arterial vasoconstriction. Speciﬁcally it
catalyses the conversion of angiotensin I to angiotensin II by removal of
terminal amino acids which led to vasoconstriction. In addition, it degrades
bradykinin, a vasodilator. The net eﬀect of these two actions is to constrict
arterial vessels. ACE inhibition is therefore a target for pharmaceutical
research as it can treat a variety of conditions such as hypertension and
type II diabetes. ACE has been studied extensively and therefore makes it
very suitable for retrospective analysis.
To validate the interpretive ability of the TMACC descriptors the ACE
data set was used. ACE induces hypertension, which makes it a popular
pharmaceutical target.164 The original TMACC work only brieﬂy covered
interpretation. With NCW it is now possible to assess a whole data set
with greater ease. Melville’s implementation created leave-one-out (LOO)
cross-validation PLS models. Melville wrote a PLS algorithm before it was
added to Weka. The q2 for this model is 0.70, which matches the original
values reported.85 The data set consists of 114 molecules and was originally
constructed for a 3D QSAR study.135 TMACC descriptors do not require
3D coordinates, only the 2D connection tables. Activity is determined by
IC50 values. IC50 is the half maximal inhibitory concentration, the amount
of a compound required to inhibit a given biological response by 50%. Sev-
eral studies determined IC50 using the substrate hippuryl-histidyl-leucine
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(HHL).165,166 One method is to measure the rate of hippuric acid production
from HHL catalysed by ACE.167 However, it was subsequently discovered
that HHL is a C-terminal domain speciﬁc substrate of ACE.168,169 This data
set consequently is likely to reﬂect that of C-terminal domain speciﬁc ACE
inhibition, rather than general inhibition.
To demonstrate the TMACC interpretation is highlighting pharmaco-
logically interesting features, a retrospective analysis must be performed.
From the literature several, potentially important features are extracted
and shown in Figure 5.1. This data set contains three commercial com-
pounds which are all licensed ACE inhibitors, captopril, enalaprilat and
lisinopril. Applying these features to the known commercial inhibitors in
Figure 5.2 a corroboration can be seen.
Figure 5.1: ACE inhibitor features investigated. Position of features shown
in 2D relation to one another. Blue circles surround atoms studied for
activity.
An essential feature is the presence of a zinc coordinating group. The
catalytic zinc iron is coordinated by three highly conserved resides present
in both domains. The functional role of the zinc ion in the active site has
led to the development of peptide based inhibitors, such as enalaprilat. The
importance of zinc binding has been shown in the crystal structure170 and
SAR studies.171 Three zinc binding groups present in the data set are inves-
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C
Figure 5.2: TMACC interpretation of ACE inhibitors. A. Captopril. B.
Enalaprilat. C. Lisinopril.
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tigated: sulfhydryl, carboxylate and phosphinate/phosphate. All sulfhydryl
sulfur atoms were identiﬁed as positive contributors towards activity. Anal-
ysis of phosphinate zinc binding groups showed all phosphorus atoms were
labelled as positive for activity. However, phosphinyl oxygen atoms were
mostly shown as negative for activity. In contrast, the interpretation most
frequently identiﬁed both carboxylate zinc binding group oxygen atoms to
be positive for activity, although the results do not fully capture the cor-
relation between the type of zinc-ligand and inhibitor activity observed in
structure-activity studies, (phosphinate carboxylate sulfhydryl).90 Perhaps
the negative activity attributed to the phosphinate oxygen atoms reﬂects its
weak zinc-binding ability in comparison to the other zinc binding groups.
The central carbonyl group is a feature found in most ACE inhibitors.
It forms two hydrogen bonds within both domains of ACE.172,173 Dock-
ing studies suggest this interaction is frequently present in ACE-inhibitor
binding and it has been identiﬁed in many ACE-inhibitor crystal structure
complexes (Figure 5.3).174 Mutation of 513His to alanine causes a 120,000-
fold decrease in the binding of lisinopril to the C-domain of somatic ACE
(sACE).175 This suggests the interaction of the conserved histidine residues
with the carbonyl group of an inhibitor is important for ACE inhibition.
The TMACC interpretation identiﬁed the central carbonyl as favourably
contributing towards the activity (Table 5.1). The high frequency of posi-
tive activity shown for this feature by the TMACC interpretation is consis-
tent with the aforementioned literature. The features highlighted in Table
5.1 have resonance structures, for example the ﬁrst three C-terminal fea-
tures. The TMACC descriptors do not have any knowledge of resonance
structures. However, all nonpolar hydrogens are treated implicitly, so the
interpretation diagrams do show a particular contributing structure, which
is what the descriptors values are based on. It is not unusual for cheminfo-
matics techniques to ignore resonance.
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Activity
ACE inhibitor feature Negative Neutral Positive
C-terminal carboxylate carbonyl 5 0 105
C-terminal carboxylate hydroxyl 0 5 105
Central carbonyl 13 3 96
Zinc binding carboxylate - carbonyl 3 3 22
Zinc binding carboxylate - hydroxyl 0 4 24
Zinc binding sulfhydryl sulfur 0 0 33
Zinc binding phosphinate phosphorus 0 0 22
Zinc binding carbonyl 20 0 2
Zinc binding hydroxyl 20 0 2
P1’ methyl 4 2 27
P1’ lysyl nitrogen 0 0 20
Table 5.1: Frequency of activity of ACE inhibitor features as determined
by the TMACC interpretation.
The crystal structures of testicular ACE (tACE) in complex with vari-
ous inhibitors (Figure 5.3) show the intermolecular interactions responsible
for ACE inhibition in tACE and correspondingly the C-terminal domain of
sACE.171,172,174 In contrast to most zinc protease inhibitors, which primar-
ily rely on the strength of their zinc binding groups for activity, domain-
speciﬁc ACE inhibitors utilize weak zinc binding groups and exploit both
primed and unprimed sides of the active site in order to mimic peptide sub-
strates, thereby achieving domain selective inhibition.176 Domain-speciﬁc
inhibition of ACE is important, as each domain possesses individual func-
tions.177 This discovery has developed the number of applications of ACE
inhibitors, extending from treating hypertension to protecting stem cells
during chemotherapy.178 A recent study has also suggested ACE may be
involved in many physiological processes other than blood pressure regula-
tion.179
The two domains of sACE contain many conserved residues, which are
vital for substrate and inhibitor binding (Table 5.2). The identiﬁcation of
conserved residues within ACE and their role in inhibitor binding has high-
lighted several important features required for ACE inhibition, providing a
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Figure 5.3: Conserved ACE residues that interact with lisinopril. A) tACE
active site (green).172 B) The N-domain active site of sACE (purple).173
Zinc ion shown in magenta; atoms are coloured as follows: red for oxygen,
blue for nitrogen, cyan for carbon and grey for hydrogen.
rationale for the structure-activity relationship of ACE inhibitors.
A C-terminal carboxylate is found in many ACE inhibitors. This fea-
ture interacts with several conserved residues in both domains of sACE,
hydrogen bonding with tyrosine and glutamine residues, and also forms an
electrostatic interaction with a lysine residue (Figure 5.3). Both C-terminal
carboxylate oxygen atoms were identiﬁed as positive by the TMACC inter-
pretation (Table 5.1).
Despite the high level of conserved residues present in both domains of
sACE, variation between the domains confers diﬀerent substrate and in-
hibitor preferences. The presence of hydrophobic residues 379Val and 380Val
in the S1’ sub-site of the C-domain of sACE provides hydrophobic interac-
tions between the sub-site and the P1’ residue of inhibitor molecules, such
as the P1’ methyl group of captopril and enalaprilat.173 The correspond-
ing residues found in the N-terminal domain, 357Ser and 358Thr, provide
a polar environment and, therefore, do not form similar hydrophobic in-
teractions with the P1’ residue of inhibitors.173,174 In the C-terminal do-
main the lysyl chain of lisinopril extends into the S1’ sub-site and forms an
electrostatic interaction with 162Glu and a water-mediated interaction with
377Asp.172 However, in the N-terminal domain the S1’ sub-site makes fewer
contacts with the lysyl chain of lisinopril (Figure 5.4). For example, 162Glu
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Functional interaction C-domain residue N-domain residue
Zinc-binding 383His 361His
Zinc-binding 387His 365His
Zinc-binding 411Glu 389Glu
Inhibitor carbonyl hydrogen
bonding
513His 491His
Inhibitor carbonyl hydrogen
bonding
353His 331His
Inhibitor carboxy terminal
carboxylic ionic bonding
511Lys 489Lys
Inhibitor carboxy terminal
carboxylic hydrogen bond-
ing
281Gln 259Gln
Inhibitor carboxy terminal
carboxylic hydrogen bond-
ing
520Tyr 498Tyr
Table 5.2: Conserved ACE residues important for inhibitor interactions.
Table formulated using information from refs170,173,180
(C-domain) is replaced by 140Asp (N-domain), and due to the larger dis-
tance between the lysyl chain and this residue, no electrostatic interaction
is observed at this location in the N-domain.173 Additionally, 377Asp (C-
domain) is replaced by 355Gln (N-domain), thereby abolishing the water-
mediated interaction shown between the lysyl residue of lisinopril and the
C-domain.173 This evidence suggests that methyl and lysyl groups located
in the P1’ position of ACE inhibitors can form favourable interactions with
the S1’ sub-site of the C-terminal domain of sACE.
Interestingly, the TMACC interpretation identiﬁed all inhibitor P1’ ly-
syl nitrogen atoms as favourably contributing towards activity (Table 5.1).
The interpretation also identiﬁed inhibitor P1’ methyl groups as positive for
activity. Thus, the TMACC interpretation identiﬁed P1’ groups important
for C-domain speciﬁc ACE inhibition, as illustrated in Figure 5.2. This
C-domain speciﬁc bias in the data set, reﬂected by the TMACC interpreta-
tion, has not been shown in previous QSAR investigations using this data
set.88,135
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Figure 5.4: Comparison of the S1’ sub-site residues which bind the lysyl
group of lisinopril. A) tACE (green)172 and B) the N-terminal domain of
sACE (purple).173
5.3.2 Solubility challenge
The measurable component of the solubility challenge relates to predictive
accuracy on an external test set. Therefore, the steps we have taken aim
to optimise this. We used a selection of methods from Weka to analyse our
training set, based on the ten-fold cross-validated correlation coeﬃcient, q2.
From Weka we tried support vector regression (SVM and SMO variants),
PLS and M5P.181,182 M5P is the Weka implementation of the M5 system
which constructs tree-based piecewise linear models. We report on the 89
training data using standard TMACC descriptors, see Table 5.3. We also
reduce the number of descriptors to those that include either one or both
components relating to solubility. At this stage we use the default parame-
ters for all techniques from Weka. By imposing a criterion on the TMACC
atomic pairs, the number of descriptors drops dramatically, see Table 5.4.
M5P does not perform as well as the support vector regression or PLS. In
addition only using descriptors which both contain a solubility component
has a detrimental eﬀect on the overall prediction. Both of these avenues
are not explored further. Both support vector variants have similar per-
formances. However, SVM is dropped in favour of SMO. Now with two
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TMACC options Solubility (µg/mL) q2
SVM SVR PLS M5P
Default S 0.17 0.17 0.13 0.00
logS 0.65 0.65 0.62 0.40
One S S 0.27 0.27 0.09 0.11
logS 0.66 0.66 0.67 0.43
Both S S 0.13 0.13 0.07 0.05
logS 0.44 0.44 0.25 0.23
Table 5.3: Weka classiﬁers with multiple TMACC variants. SVM: Support
vector regression using SMO, weka package SMOreg. SVR: Support vector
regression using the weka package SVMreg. PLS: Partial Least Squares.
M5P: Tree-based model based on the M5 system.
TMACC variant Number of attributes
Default 617
One logS component 287
Both logS components 67
Table 5.4: Number of attributes in diﬀerent variants of TMACC. Number
of logS components refers to those included.
Descriptor SVM SMO PLS
MAE RMSE MAE RMSE MAE RMSE
Default 0.81 0.99 0.81 0.99 0.92 1.12
One logS 0.76 0.99 0.76 0.99 0.80 1.05
Table 5.5: Errors for the cross-validation for the three techniques.
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Cutoﬀ SMO PLS
q2 MAE RMSE q2 MAE RMSE
None 0.66 0.76 0.99 0.67 0.80 1.05
19 0.66 0.76 0.99 0.68 0.80 1.05
17 0.66 0.75 0.98 0.67 0.81 1.08
13 0.67 0.75 0.98 0.66 0.83 1.08
11 0.63 0.76 1.02 0.46 1.08 1.43
6 0.30 0.96 1.24 0.12 1.83 2.39
Table 5.6: Final two techniques with cutoﬀ of maximum topological distance
Property Default Minimum Maximum Step
C 1 1 20 1
γ 0.01 1.0×10−5 1.0×10+2 1
ǫ 0.001 1.0×10−5 1.0×10+2 1
Table 5.7: GridSearch for C, γ and ǫ. Step increment applies only to the
exponent, except C.
techniques we look at optimising them and reducing the maximum distance
of the topological bond distance. From this point, we only use the one logS
component TMACC variant, as it outperforms the default TMACC. The
q2 value does not alter. However, the error values decrease before the q2
suddenly drops. PLS has consistently higher errors and similar q2 values.
Therefore, the SMO variant of support vector regression is chosen as the
best technique. Further modiﬁcation of the TMACC is achieved by apply-
ing a cutoﬀ to the topological distance component. Table 5.6 shows various
cutoﬀ results, from which 13 is reasonable and used from now on.
Finally, further optimisation on support vector regression can be per-
formed. The RBF kernel is known to perform well. Next we tune three
parameters, C, γ and ǫ, which represent the complexity constant, the RBF
width and the round-oﬀ error, respectively. A grid search is possible within
Weka for two components, optimising for q2. C and γ are optimised ﬁrst,
then C and ǫ.
The GridSearch reveals for SMO with an RBF kernel using the 13 cutoﬀ
TMACC that C should be 1, with γ = 0.001 and ǫ = 0.1 (See Table 5.7).
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These are the parameters used in SMO for our predictions, detailed in Table
5.8. Figure 5.5 shows the observed versus predicted data for the training
data. Figure 5.6 shows the cross-validated results for the same data. All
test predictions are within the same range as the training observations.
Figures 5.7, 5.8 and 5.9 display the observed versus predicted solubilities
for the three compound sets 32, 28 and 24 respectively. Test compounds
which were classed as “Too Soluble to Measure” are not included in these
plots. The extra lines on this graph show the 0.5 log unit zone where correct
predictions are counted.
Figure 5.5: Predicted versus observed solubility for the training data (r 2 =
0.79).
Using the interpretation from the TMACC some known trends can be
seen. Halogens reduce solubility and increase lipophilicity as seen in 5.11.
The colour scheme is depicted in Figure 5.10. Cyclopropane is reactive and
hence good for solubility as demonstrated by 5.12.29
In terms of the solubility challenge we generally did not score highly
against the other entries. The scoring criteria were as follows, (a) Percent-
age correct of full test set (32 compounds). (b) Percentage correct from
soluble compounds (28 compounds). (c) r 2 of 28 compounds. (d) Per-
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Figure 5.6: Predicted versus observed solubility for the cross-validated data.
For the solubility challenge the predictions must fall with ± 0.5 log units to
be considered correct.
Figure 5.7: Predicted versus observed solubility for the 32 molecule set.
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Figure 5.8: Predicted versus observed solubility for the 28 molecule set.
Figure 5.9: Predicted versus observed solubility for the 24 molecule set.
Figure 5.10: TMACC colour scheme
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Compound Observed solubility Predicted solubility
(µg/mL) (µg/mL)
1 acebutolol 711 177
2 amoxicillin 3900 4416
3 bendroﬂumethiazide 780 150
4 benzocaine 780 1754
5 benzthiazide 6.4 15
6 2-chloromandelic acid too soluble to measure 869
7 clozapine 189 46
8 dibucaine 14 22
9 diethylstilbestrol 10 204
10 diﬂunisal 26, 7.6, 0.93, 0.29 12
11 dipyridamole 3.46 29
12 1R-2S-ephedrine too soluble to measure 288
13 folic acid 2.5 14
14 furosemide 19.6 13
15 hydrochlorothiazide 625 195
16 imipramine 22 49
17 indomethacin 410 86
18 ketoprofen 157 69
19 lidocaine 3130 762
20 marboloxacin too soluble to measure 1807
21 meclofenamic acid 0.16 3
22 naphthoic acid 28.96 195
23 1R-2R-psuedophedrine too soluble to measure 32
24 probenecid 3.9 288
25 pyrimethamine 19.4 5
26 salicylic aicd 620 401
27 sulfamerazine 200 475
28 sulfamethizole 450 279
29 terfenadine 0.00856 99
30 thiabendazole 66 676
31 tolbutamide 93 45
32 trazodone 460, 127 0.834
Table 5.8: Test set compounds and their observed and predicted logS values.
Compound 10 has multiple entries to represent the four polymorphs it forms.
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A B
C D
Figure 5.11: A amiodarone, B diazoxide, C hydrochlorothiazide & D
pyrimethamine. The present of a halogen has increased lipophilicity and
therefore reduced solubility.
110
A B
C D
Figure 5.12: A ciproﬂoxacin, B danoﬂoxacin, C enroﬂoxacin & D
sparﬂoxacin. Cyclopropane is reactive and good for solubility.
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Molecules 32 28 24
Criteria a (%) b (%) c (r 2) d (%) e (r 2)
S 60 62 3 62 3
logS 57 63 74 63 51
Table 5.9: Results of solubility challenge, ranks against the other 99 en-
trants.
centage correct from soluble compounds minus the four largest outliers (24
compounds). (e) r 2 of 24 compounds. This was done for both S and logS
values. For S to be considered correct it had to be within ± 10% of the
actual value. For logS ± 0.5 logS units of the observed value was required
to be considered correct. Our models were generated using logS values;
using S produced poor r 2 values. The logS values were converted to S for
the purpose of scoring. However, our r 2 values on the 28 and 24 compound
subsets were excellent compared to other entrants. Our excellent r 2 values
are somewhat surprising given zero compounds were correct by the criterion
set. This is an artefact of the arbitrary nature of a clear cut criterion. Our
ranks for all ﬁve measures against the other 99 entrants are in Table 5.9.
Our logS r 2 values were not quite as impressive. The r 2 for the 28 molecule
set is worse than the 24 molecule set. This is because the 4 outliers which
were removed were on average 2.3 log units incorrect in their predictions.
The large error associated with these 4 outliers reduced the overall r 2. Our
results are shown in Table 5.10 along with the best and median performance
from all other entrants. The logS criterion of ± 0.5 logS units is unduly
harsh. Assuming a criterion of ± 1.0 logS our results fare better. The
percentage of correct predictions for the 32 molecule set is 71.9% instead
of 37.5%. For the 28 molecule set, it is 75.0% instead of 35.7%. For the
24 molecule set 75.0% instead of 41.7%. These results demonstrate that
for logS our method is relatively successful, against this relaxed but not
unrealistic error range.
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Molecules 32 28 24
Criteria a (%) b (%) c (r 2) d (%) e (r 2)
TMACC S 6.3 0.0 0.625 0.0 0.941
logS 37.5 35.7 0.269 41.7 0.621
Best S 21.9 17.9 0.642 20.8 0.987
logS 62.5 60.7 0.650 70.8 0.835
Median S 9.4 3.6 0.082 4.2 0.494
logS 43.8 42.9 0.360 50.0 0.622
Table 5.10: Results of solubility challenge, against performance markers.
The best and median results are also shown for comparison.
5.4 Conclusions
In previous work, the TMACC descriptors have proved to be competitive
against 2D and 3D methods, but the interpretative ability of these de-
scriptors was only brieﬂy touched upon. In order to make interpretation
readily available, new computational tools were required to carry out addi-
tional calculations on the PLS model and FGRAM output. NCW encom-
passes the original software and provides the extra functionality to build
the PLS model. The PLS model and FGRAM output are then used to
calculate atomic contributions for each atom in the data set. The results
are binned into ﬁve colour-coded categories, which are depicted using the
ChemAxon Marvin suite. NCW allows models to be generated and inter-
preted quickly. The results shown here illustrate that the interpretation
produced by TMACC is indeed chemically valid. There is scope for fur-
ther automation of the interpretation, particularly automatic recognition of
features of importance. Currently, the user is required to identify relevant
information.
Analyses of the TMACC QSARs modelled for the ACE data set have
shown that the TMACC interpretation can identify distinctive features of a
structure-activity relationship. The TMACC interpretation provided a clear
and precise representation of the activity of speciﬁc groups. Amalgamation
of the atomic activity values determined for such groups within a data
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set, showed strong correlation with experimental evidence, which shows the
TMACC interpretation can produce models which accurately depict the
features of a structure-activity relationship.
Overall, the TMACC interpretation of the ACE inhibitor structure-
activity relationship highlighted important features for C-domain selective
ACE inhibition. The TMACC interpretation provided a consistent rep-
resentation of the structure-activity relationship present in the ACE data
set, albeit limited by the size of the data set. To obtain a more detailed
analysis of components important or detrimental to the ACE inhibitor
structure-activity relationship, it would be necessary to investigate a data
set which represents a comprehensive range of functional groups and struc-
tural components. Investigation of the activity of features important for
C-terminal domain selective inhibition in comparison to features important
for N-terminal domain selective inhibition would provide further insight into
the interpretive ability of the TMACC descriptors.
An inherent weakness, due to the 2D nature of the TMACC descriptors,
is insensitivity to chirality. However, the use of chirality descriptors derived
from topological data may provide a solution to this limitation and may
also improve the predictive ability of the QSAR models.183 Investigation
of alternative or additional atomic properties used in the TMACC descrip-
tors would provide an insight into the properties which contribute towards
activity. The eﬀect of implementing more sophisticated partial charge cal-
culations would be interesting, as a recent study has suggested that the
method used for partial charge calculations can aﬀect QSAR predictive ac-
curacy.184 Investigation of a wider range of data sets would provide further
validation of the utility of the TMACC interpretation.
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Chapter 6
Conclusions
There has never been a more pressing time in drug discovery to reduce
development time and cost. In silico techniques oﬀer inexpensive methods
to assist in early stage development. QSAR is just one of many techniques
available from cheminformatics. This thesis has covered various aspects of
QSAR from model choice and optimisation, to descriptors and appropriate
statistics.
The so called patent cliﬀ aﬀects all major pharmaceutical companies.
Virtually all top ten billion-dollar blockbusters come oﬀ patent in the next
ﬁve years. There has been a reduction in new blockbusters so there are
none to replace them. When Lipitor185 goes oﬀ patent for Pﬁzer, it will
leave a huge revenue gap. Pharma realises it is no longer the norm to have
a few billion dollar blockbusters. It is not the lack of candidate drugs, but a
lack of successful candidate drugs. The cost of clinical trials is prohibitive,
especially if a compound has borderline pre-clinical results. At the same
time registration has become more rigorous, following high proﬁles cases of
negative, unknown, side eﬀects, e.g. Vioxx.186 In addition, only new in class
or better than existing in class drugs will get registered. While a company
may improve treatment and eﬃcacy of a patented compound, if it does not
outperform the market leader registration will not be granted. Competition
from generics is now ﬁerce. They do not wait for patents to expire and are
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increasingly challenging existing patents, in some cases successfully. In turn
this makes the original patent even more important, as it is required to be
watertight and withstand challenge for the duration of the patent.
Pharma already employs a variety of methods to extend patents. Clin-
ical trials on children earn an extra six months. Revising the dosage or
combination therapy requires a new application, thus extending the total
time of protection. To combat the competition from generics, once drugs
go oﬀ-patent some companies have either bought into or set up their own
generics divisions. Following the global trend of outsourcing some R&D
have moved to Asia: India and China, primarily. The lure is no diﬀerent
to any other industry, cheaper labour than western counterparts. However,
it has not been smooth. For example Novartis has had trouble securing
intellectual property over their research. Regardless of the approach to en-
sure more compounds reach clinical trials and are successfully registered,
the starting point of lead generation is perhaps the most important step.
This is where cheminformatics comes in.
Throughout this thesis core components of QSAR have been covered.
Every choice made before building the model is important as it aﬀects
the potential outcome and therefore usefulness of it. Data mining oﬀers
a plethora of techniques to build a model upon, each with advantages and
disadvantages. One needs to generate a reasonably sized data set. Data is
not always readily available. If the data set is to be split into train, hold
and test sets, this requires careful handling to ensure the sets are equally
distributed. Having a test set containing the most obscure or outliers is not
sensible. Descriptors will need to be generated. However, there are thou-
sands to pick from again, with advantages and disadvantages. Actually
building the model will likely take less time than the data preparation and
associated decision process. Ideally one will want to extract some insight
from the model - this is dependent on the model and the descriptors picked.
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How do we move this process forward? The machine learning community
produces new techniques and it is not long before cheminformatics and
bioinformatics practitioners try them. Popular methods will get attention
and will be modiﬁed to suit the task at hand. Examples include adding
interpretability to neural networks and creating chemical kernels for SVM.
Another avenue becoming increasingly popular is the idea of AutoQSAR.187
Once one has built a model it is a static snapshot. In pharma, particularly,
more data will become available and the model could and arguably should
be updated. AutoQSAR has dynamic models which are constantly refreshed
using new data and even descriptors. Such as system makes QSAR available
to non-experts as they do not need to build the model. However, rigorous
validation is necessary as it is all to easy to generate hundreds of poor
models that are assumed correct by non-experts.
We have attempted to advance QSAR in several ways. Firstly, we have
explored the interpretive abilities of the TMACC descriptors beyond the
original work. Secondly, we have advocated the use of appropriate statis-
tics for comparison of multiple classiﬁers and data sets. Most methodology
articles include some sort of comparison to highlight reported advances.
Appropriate statistics are vital for assessing a given advance as “statisti-
cally signiﬁcant”. Thirdly, we have extended the interpretive ability of the
random forest. Random forest is a competitive technique compared to the
benchmark SVM. However, relatively little work has been carried out in-
terpreting the model. We have addressed this by introducing FBI to aid
modellers analyse their forests. The TMACC descriptors oﬀer competitive
and interpretive descriptors for QSAR. Thanks to the development of NCW
their generation, model building and analysis is far more practical than pre-
viously. NCW provides a complete work ﬂow solution and importantly aids
in interpretating one’s results. Throughout our comparison work it became
clear that the ability of learning classiﬁers is high and competitive. Inter-
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estingly they use completely diﬀerent approaches to achieve high predictive
accuracies. It transpires comparing multiple classiﬁers with multiple data
sets is not an appropriate use of the t-test. More relevant techniques are
required and we highlight several more applicable statistic tests.
We had a speciﬁc interest in trees due to their familiarity. Our advances
in forest interpretation are numerous over the previous simple counts. The
various approaches mentioned all can aid one in gaining insight to a non
black box method that is no longer simple to understand.
QSAR has developed a lot, since its original conception by Hansch. It
has had numerous advances and successful applications. This work aims to
continue this development further. Throughout, we have shown that our
developments can aid the community at large, especially as we release the
software packages produced with open source licenses.
There are several avenues for this work to continue. Both NCW and
FBI are suitable platforms to further develop without the need to rewrite
the base code. Both programs give access to new interpretations. A core
competency moving forward would be the ability to automatically extract
a summary of the presented interpretation.
The TMACC descriptor construction should be further investigated.
This was touched upon in Chapter 5 where the presence of the logS compo-
nent in the descriptor pairs was set as one or both. This could be extended
to the other descriptors which are deemed as important for a given dataset.
Additionally, new atomic properties could be made available to build the
complete TMACC descriptor. This would increase dimensionality of the de-
scriptor which is not necessarily desirable. One could build the full TMACC
of x atomic properties and perform a feature selection like approach to re-
duce which properties are most important in this model. This would leave
a subset of the atomic properties and a smaller descriptor which would be
targeted for a given data set. NCW has made inspection of the TMACC
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straight forward but it is very labour intensive. Ideally NCW should at-
tempt to present the user with atomic features of interests. For example,
those features which occur frequently throughout the data set. If you know
what structural elements are important you can look for them, but this will
not uncover some novel interpretation that the model may of detected. The
TMACC interpretation are graphs. Reduced graphs are a descriptor that
capture important interactions that may represent several atoms.188 You
do not want to look for atomic interactions, but the trends, often several
atoms contribute to an aﬀect. However, the ﬁne granularity of the TMACC
interpretation forces an atomistic approach. Viewing the interpretation as
reduced graphs would be desirable and could be the output from an auto-
mated feature detection. Although this thesis has focussed on 2D techniques
the TMACC could be implemented as a 3D descriptor for pharmacophore
related work.
Within NCW the ability to interrogate the forest contents is now pos-
sible. Further tools would aid this endeavour. Like the TMACC interpre-
tation there is still a large manual component required currently. It would
be useful for NCW to suggest subgraphs of potential interest between the
trees, perhaps starting with those which occur frequently. A pathway anal-
ysis could weight each pathway (from the root node to terminal leaf node)
through the tree based on the number of molecules at each node. This
weighted pathway could be useful in ranking subgraphs of potential inter-
est. With a well understood data set looking for known chemistry is fairly
straightforward. What is more interesting is if NCW can detect unknown
chemistry, such as a new mode of action. The challenge here is how do
you know one has uncovered some novel information and not noise. Other
enhancements would include the ability to read random forest models from
R and other popular implementations. The tree visualiser provided from
Weka does not handle large trees very well, which is generally what Weka
119
produces. An alternative tree visualiser using a hyperbolic view would make
visual inspection more practical.
There is an overriding theme of simplifying the interpretation of the
results from both programs. Although there is no need to rewrite the
base code it could be ported to other Java applications that receive more
widespread usage by cheminformatians, such as KNIME36 and the Chem-
istry Development Kit (CDK).189
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Chapter A
Appendix
A.1 Solubility challenge structures
These are the original structures provided for the solubility challenge.28
Table A.1 lists the training data and solubility data. Table A.2 contains
the test structures, with unknown solubility values.
Table A.1: Solubility training set compounds
Number Compound name Structure
1 1-Naphthol
2 2-amino-5-bromobenzoic acid
Continued on next page
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Table A.1 – continued from previous page
Number Name Structure
3 4-Iodophenol
4 5-bromo-2,4-dihydroxybenzoic acid
5 5-ﬂuorouracil
6 Acetaminophen
7 Acetazolamide
Continued on next page
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Table A.1 – continued from previous page
Number Name Structure
8 Alprenolol
9 Amantadine
10 Amiodarone
11 Amitriptyline
12 Amodiaquine
Continued on next page
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Table A.1 – continued from previous page
Number Name Structure
13 Aspirin
14 Atropine
15 Azathioprine
16 Benzylimidazole
17 Bromogramine
Continued on next page
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Table A.1 – continued from previous page
Number Name Structure
18 Bupivacaine
19 Carprofen
20 Carvedilol
21 Cephalothin
22 Chlorphenamine
Continued on next page
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Table A.1 – continued from previous page
Number Name Structure
23 Chlorpromazine
24 Chlorpropamide
25 Chlorprothixene
26 Chlorzoxazone
27 Cimetidine
Continued on next page
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Table A.1 – continued from previous page
Number Name Structure
28 Ciproﬂoxacin
29 Danoﬂoxacin
30 Deprenyl
31 Desipramine
32 Diazoxide
Continued on next page
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Table A.1 – continued from previous page
Number Name Structure
33 Diclofenac
34 Diﬂoxacin
35 Diltiazem
36 Diphenhydramine
37 5,5-diphenylhidantoin
Continued on next page
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Table A.1 – continued from previous page
Number Name Structure
38 Enroﬂoxacin
39 Famotidine
40 Fenoprofen
41 Flufenamic acid
42 Flumequine
Continued on next page
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Table A.1 – continued from previous page
Number Name Structure
43 Flurbiprofen
44 Glipizide
45 Guanine
46 Hexobarbital
47 Hydroﬂumethiazide
Continued on next page
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Table A.1 – continued from previous page
Number Name Structure
48 4-Hydroxybenzoic acid
49 Ibuprofen
50 Levoﬂoxacin
51 Lomeﬂoxacin
52 Loperamide
Continued on next page
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Table A.1 – continued from previous page
Number Name Structure
53 L-Proline
54 Maprotiline
55 Meclizine
56 Mefenamic acid
57 Metoclopramide
Continued on next page
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Table A.1 – continued from previous page
Number Name Structure
58 Metronidazole
59 Miconazole
60 Nalidixic Acid
61 Naloxone
62 Naproxen
Continued on next page
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Table A.1 – continued from previous page
Number Name Structure
63 Niﬂumic acid
64 Nitrofurantoin
65 Norﬂoxacin
66 Notriptyline
66 Oﬂoxacin
Continued on next page
156
Table A.1 – continued from previous page
Number Name Structure
67 Orbiﬂoxacin
68 Oxytetracycline
69 Papaverine
70 Pen G
71 Phenantroline
Continued on next page
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Table A.1 – continued from previous page
Number Name Structure
72 Phenazopyridine
73 Phenobarbital
74 Phenylbutazone
75 Phthalic acid
76 Pindolol
Continued on next page
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Table A.1 – continued from previous page
Number Name Structure
77 Piroxicam
78 Procainamide
79 Procaine
80 Propanolol
81 Quinine
Continued on next page
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Table A.1 – continued from previous page
Number Name Structure
82 Ranitidine
83 Saraﬂoxacin
84 Sertraline
85 Sparﬂoxacin
86 Sulfacetamide
Continued on next page
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Table A.1 – continued from previous page
Number Name Structure
87 Sulfamethazine
88 Sulfasalazine
89 Sulfathiazole
90 Sulindac
91 Tetracaine
Continued on next page
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Table A.1 – continued from previous page
Number Name Structure
92 Tetracycline
93 Thymol
94 Tolmetin
95 Trichlomethiazide
96 Trimethoprim
Continued on next page
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Table A.1 – continued from previous page
Number Name Structure
97 Trimipramine
98 Tryptamine
99 Verapamil
100 Warfarin
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Table A.2: Solubility test set compounds
Number Compound name Structure
1 Acebutolol
2 Amoxicillin
3 Bendroﬂumethiazide
4 Benzocaine
5 Benzthiazide
Continued on next page
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Table A.2 – continued from previous page
Number Name Structure
6 2-chloromandelic acid
7 Clozapine
8 Dibucaine
9 Diethylstilbestrol
10 Diﬂunisal
Continued on next page
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Table A.2 – continued from previous page
Number Name Structure
11 Dipyridamole
12 Ephedrine
13 Folic Acid
14 Furosemide
15 Hydrochlorothiazide
Continued on next page
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Table A.2 – continued from previous page
Number Name Structure
16 Imipramine
17 Indomethacin
18 Ketoprofen
19 Lidocaine
20 Marboﬂoxacin
Continued on next page
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Table A.2 – continued from previous page
Number Name Structure
21 Meclofenamic acid
22 Naphthoic acid
23 Probenecid
24 Pseudoephedrine
25 Pyrimethamine
Continued on next page
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Table A.2 – continued from previous page
Number Name Structure
26 Salicylic acid
27 Sulfamerazine
28 Sulfamethizole
29 Terfenadine
30 Thiabendazole
Continued on next page
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Table A.2 – continued from previous page
Number Name Structure
31 Tolbutamide
32 Trazodone
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